Podcasts about Doblin

Ospite della 131° puntata di Illuminismo Psichedelico è Rick Doblin, fondatore e presidente della Multidisciplinary Association for Psychedelic Studies (MAPS) ed ex membro del consiglio di amministrazione di Lykos Therapeutics. Insieme a Doblin abbiamo parlato della sua scoperta e del suo rapporto con l'MDMA, di come questo abbia ispirato la nascita di MAPS e le ricerche per consentire un uso terapeutico della sostanza, ma anche di come poi le cose siano andate male, a causa della concorrenza di altre entità che chiedevano fondi per ricerche sugli psichedelici MAPS è stata costretta a generare una costola "for profit", Lykos, che ben presto è diventata un "lupo tra i lupi", e Doblin ha deciso di lasciarla, mostrandosi molto critico con come la nuova entità ha scelto di comunicare ma anche di difendere i risultati della fase 3 dei trial sull'MDMA, bocciati nella scorsa estate dalla FDA. 

In this episode, Joe interviews Rick Doblin, Ph.D.: founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS), and former board member at Lykos Therapeutics, MAPS' public benefit subsidiary. Doblin tells his side of the story: that the FDA's concerns with double blinding not working had been fully addressed ahead of time, that they had negotiated agreements that were no longer agreed to when new FDA employees came on board, that there was a lot of confusion from going back and forth with the FDA on how Phase 3 studies should be designed, and more. He believes that Lykos made a massive mistake in assuming that provable science was more important than public opinion, and that ignoring critics who were saying whatever they wanted caused them to lose control of the narrative – which clearly influenced the advisory committee. While Lykos figures out their next steps with the FDA, MAPS is focusing their attention on what they feel is most important in light of this ruling: better public education and drug policy. He talks about: How there's a bias at the FDA to be harsh: Does automatically saying no just make it look like you're being rigorous? The work of the Dutch government in researching MDMA, and Lykos' odd decision to not highlight any of it Massachusetts' Legalization and Regulation of Psychedelic Substances initiative, and the huge opportunity for progress at the local level Why federal agents at Burning Man work so hard to give tickets to attendees for smoking cannabis Why sharing stories of your positive experiences with psychedelics is so important and more!  MAPS has announced that 2025's Psychedelic Science conference will be in Denver, June 16-20, and will have experiential opportunities before and after.  For links, head to the show notes page. 

Welcome back to The Trip Report Podcast, a production of Beckley Waves, a Psychedelic Venture Studio.Today, I am speaking with Rick Doblin, founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS).December of last year was a milestone for Doblin and MAPS, as the organization submitted a New Drug Application for MDMA Assisted Therapy to the United States Food and Drug Administration.Then, in the first week of January, the MAPS Public Benefit Corp announced its rebranding to Lykos Therapeutics and a $100 million Series A financing.Needless to say, it has been a pivotal period in the organization's history and a watershed moment for the revival of psychedelic medicine, science, and policy.In February, the FDA accepted the application and granted a priority review, putting the decision timeline at August of this year.That's just around the corner.And so much is still up in the air—of course the big question—will the FDA grant approval? But also so many granular details that will have significant downstream effects on the commercial rollout, access, and cost.* What language will be on the drug label? * What will the Risk Evaluation and Mitigation Strategy entail? * How will patients be able to access the drug? * What will the FDA say about the role of therapy?Among others.So, I wanted to sit down with Rick to talk about it and get his perspective on the organization's evolution, the path ahead, and, most importantly, the many uncertainties that hang in the balance.In this conversation, we discuss:* The importance of therapy in conjunction with MDMA (and his loathing of the acronym MDMA-AT)* The many regulatory and bureaucratic details that go into the FDA's decision and subsequent commercial rollout, including:* Drug labeling* Therapist credentialing * Risk Evaluation and Mitigation Strategies* The negotiations he's led with the FDA over the last 20 years* Lykos' goal of getting MDMA-Assisted Therapy FDA approved and MAPS' goal of getting MDMA federally legalized* The role of therapist's first-hand experience with MDMA and the regulatory battle of ensuring legal access to this group* His future humanitarian and scientific plansAnd much more.And now I bring you my conversation with Rick Doblin.Listen to the episode on Substack, Spotify, Google or Apple.Credits:* Hosted by Zach Haigney * Produced by Zach Haigney, Erin Greenhouse, and Katelin Jabbari* Find us at thetripreport.com* Follow us on Instagram, Twitter, LinkedIn and YouTubeTheme music by MANCHO Sounds, Mixed and Mastered by Rollin Weary This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.thetripreport.com

My guest today on The Courage of a Leader podcast is Larry Keeley. We delved into some thought-provoking concepts and practical steps to fuel innovation.In this episode, Larry addresses the inherent fears associated with innovation, both for young innovators and senior leaders who sponsor it. By establishing well-governed, well-led, and senior executive-sanctioned frameworks for innovation, these fears can be overcome.This is not an episode to miss! About the Guest:With forty years of work as an innovation scientist, Larry Keeley works to make innovation much more effective. He is the co-founder of Doblin, the leading global firm focused on innovation effectiveness—over 700 alumnae in that network. Professor at IIT Institute of Design for 39-years, first university in the world to grant PhDs in design and innovation; Board member and leading employer of graduates. Professor at Kellogg Graduate School of Management, MMM Program for 12-years; named Distinguished Professor there, 2015. He has helped educate more than 5,900 Masters or PhD students as innovators—a huge global network ofcolleagues. Author of #2 all-time best-selling book on innovation, Ten Types of Innovation, translated into 15- languages. Selected by Business Week as one of the top seven global ”gurus” of the innovation field. Then separately selected by them as one of the top 27-designers in the world. Currently Keeley runs Keeley Innovations LLC, his own private consultancy, advising individuals and firms that he believes can change the world. This gives him complete independence, with no teams, firms, methods, or follow-on activities he is obligated to represent. About the Host:Amy L. Riley is an internationally renowned speaker, author and consultant. She has over 2 decades of experience developing leaders at all levels. Her clients include Cisco Systems, Deloitte and Barclays.As a trusted leadership coach and consultant, Amy has worked with hundreds of leaders one-on-one, and thousands more as part of a group, to fully step into their leadership, create amazing teams and achieve extraordinary results. Amy's most popular keynote speeches are:The Courage of a Leader: The Power of a Leadership LegacyThe Courage of a Leader: Create a Competitive Advantage with Sustainable, Results-Producing Cross-System CollaborationThe Courage of a Leader: Accelerate Trust with Your Team, Customers and CommunityThe Courage of a Leader: How to Build a Happy and Successful Hybrid TeamHer new book is a #1 international best-seller and is entitled, The Courage of a Leader: How to Inspire, Engage and Get Extraordinary Results.www.courageofaleader.comhttps://www.linkedin.com/in/amyshoopriley/ Links mentioned in the podcastThe Inspire Your Team assessment (the courage assessment) - https://courageofaleader.com/inspireyourteam/Ten Types of Innovation: The Discipline of Building Breakthroughs (book) by Larry Keeley - https://www.amazon.com/Ten-Types-Innovation-Discipline-Breakthroughs-ebook/dp/B00DZLBHU8Innovators Dilemma (book) by Clayton Christensen - https://www.amazon.com/Innovators-Dilemma-Technologies-Management-Innovation-ebook/dp/B012BLTM6I Thanks for listening!Thanks so much for listening...

In one final episode for 2023 / season 4 of Curiosity Killed the Rat, Kade and Matt bring you an extended special reflecting on one of the biggest Australian milestones of 2023: the re-classification and approval of MDMA and Psilocybin to assist therapy. Kade leads us through the science accompanying the historical journey of these drugs; from their discovery and synthesis, through their recreational use (both legal and illegal), to their status today as promising therapeutic compounds. Stick around for a listener question of great seriousness and importance: If a tree in the forest falls and no one is there to hear it, does it make a sound? As always, you can find us @curiosityrat on X, instagram, and facebook, and send your listener questions in to curiosityrat@gmail.com We also have a Patreon! If you love our content and want to support us you can jump on to https://www.patreon.com/curiosityrat and become a patron. There is absolutely ZERO pressure but if you have as little as $1/month you can chuck it our way to help us out and show you appreciate all the time and effort that goes into making this show. References: Kade's Article The Therapeutic Odyssey of Psilocybin and MDMA: A Return to Roots https://rsv.org.au/psilocybin-and-mdma/ Seeking the magic mushroom — Originally published in 1957 Life Magazine https://www.trippingly.net/lsd/2018/5/14/seeking-the-magic-mushroom Hofmann, A. (1959). Psychotomimetic drugs. Acta physiologica et pharmacologica Neerlandica, 8, 240-258. Shulgin, A. T. (1964). 3-Methoxy-4 5-methylenedioxy Amphetamine, a New Psychotomimetic Agent. Nature, 201(4924), 1120-1121. Stolaroff, M. J. (1997). The secret chief revealed: Conversations with a pioneer of the underground psychedelic therapy movement. Multidisciplinary Association for Psychedelic Studies (MAPS). Sessa, B., Higbed, L., & Nutt, D. (2019). A review of 3, 4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy. Frontiers in psychiatry, 10, 138. Nutt, D. J., King, L. A., & Nichols, D. E. (2013). Effects of Schedule I drug laws on neuroscience research and treatment innovation. Nature Reviews Neuroscience, 14(8), 577-585. Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011). Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Archives of general psychiatry, 68(1), 71-78. Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., & Doblin, R. (2011). The safety and efficacy of±3, 4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Journal of psychopharmacology, 25(4), 439-452. Li, N. X., Hu, Y. R., Chen, W. N., & Zhang, B. (2022). Dose effect of psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis. Journal of Affective Disorders, 296, 26-34. Carhart-Harris, R., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R., ... & Nutt, D. J. (2021). Trial of psilocybin versus escitalopram for depression. New England Journal of Medicine, 384(15), 1402-1411. Bogenschutz, M. P., Ross, S., Bhatt, S., Baron, T., Forcehimes, A. A., Laska, E., ... & Worth, L. (2022). Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial. JAMA psychiatry, 79(10), 953-962. Johnson, M. W., Garcia-Romeu, A., & Griffiths, R. R. (2017). Long-term follow-up of psilocybin-facilitated smoking cessation. The American journal of drug and alcohol abuse, 43(1), 55-60. Peck, S. K., Shao, S., Gruen, T., Yang, K., Babakanian, A., Trim, J., ... & Kaye, W. H. (2023). Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study. Nature Medicine, 29(8), 1947-1953. Danforth, A. L., Grob, C. S., Struble, C., Feduccia, A. A., Walker, N., Jerome, L., ... & Emerson, A. (2018). Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study. Psychopharmacology, 235(11), 3137-3148. Wolfson, P. E., Andries, J., Feduccia, A. A., Jerome, L., Wang, J. B., Williams, E., ... & Doblin, R. (2020). MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study. Scientific reports, 10(1), 20442. Mitchell, J. M., Bogenschutz, M., Lilienstein, A., Harrison, C., Kleiman, S., Parker-Guilbert, K., ... & Doblin, R. (2023). MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Focus, 21(3), 315-328. Nicholas, C. R., Wang, J. B., Coker, A., Mitchell, J. M., Klaire, S. S., Yazar-Klosinski, B., ... & Doblin, R. (2022). The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD. Drug and alcohol dependence, 233, 109356. Sessa, B., Higbed, L., O'Brien, S., Durant, C., Sakal, C., Titheradge, D., ... & Nutt, D. J. (2021). First study of safety and tolerability of 3, 4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder. Journal of Psychopharmacology, 35(4), 375-383. Hoshi, R., Bisla, J., & Curran, H. V. (2004). The acute and sub-acute effects of ‘ecstasy'(MDMA) on processing of facial expressions: preliminary findings. Drug and Alcohol Dependence, 76(3), 297-304. Rootman, J. M., Kiraga, M., Kryskow, P., Harvey, K., Stamets, P., Santos-Brault, E., ... & Walsh, Z. (2022). Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls. Scientific Reports, 12(1), 11091. Cavanna, F., Muller, S., de la Fuente, L. A., Zamberlan, F., Palmucci, M., Janeckova, L., ... & Tagliazucchi, E. (2022). Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study. Translational Psychiatry, 12(1), 307. Passie, Torsten, and Andrew Dennis, 'The Early History of MDMA', The History of MDMA MAPS FDA MDMA application: https://mapsbcorp.com/news/mdma-for-ptsd-fda-submission/ MDMA neurotoxicity: https://www.science.org/doi/10.1126/science.301.5639.1479b https://www.science.org/doi/10.1126/science.1074501 https://www.science.org/doi/10.1126/science.301.5639.1454b https://www.ncbi.nlm.nih.gov/pmc/articles/PMC194116/ Woke pharmaceuticals: https://wokeph.com/ Tik Tok Video: https://vt.tiktok.com/ZSNCVW7gn/

With over fifteen years of strategy consulting, start-up mentoring and corporate leadership experience, Laetitia Andrac has led many successful growth and innovative programs in many high-profile global organisations, including Telstra, Deloitte, Doblin, Capgemini, Bloomberg Philanthropies and the French Government. She understands first-hand the daily juggle of successful entrepreneurs, which can leave them feeling triggered, time-poor, spread thin and burned out. Laetitia knows these problems too well, as she experienced burnout in 2014. At the time, wrapping her head around being burned out was impossible. People like her didn't burnout. This experience taught Laetitia the importance of reconnection with her intuition to avoid burnout. She shares that in her new book, LIGHT IT : How to Trust your Intuition and Build a Thriving Business, explaining her LIGHT framework. It has helped hundreds of entrepreneurs shift from burned-out to blissed-out, reconnecting them to their intuition and inner knowing. In today's conversation we explore: - Recognising the signs of burnout - How to know if it's your intuition or fear - How to connect with your intuition and implement it into your business strategy, - recognising the difference between intuition and other emotions -Rituals to strengthen your connection to your intuition - The masculine and feminine balance required in business to avoid burnout To connect with Laetitia check out her links @essential.shift Buy the book - https://www.essentialshift.co/lightit https://www.essentialshift.co/ https://www.essentialshift.co/essential-shift-podcast WORK WITH CHRISTINE: Book a Discovery Call with Christine here Join the waitlist for the next round of ELEVATE Mastermind HERE Join the waitlist for the next round of NEXT LEVEL Mastermind HERE Free Self Sabotage Training to stop sabotaging your success - Click here CONNECT WITH CHRISTINE; Follow me @christinecorcoran_coach Hit Subscribe to the podcast + above

Have you ever pondered the extraordinary impact of blending intuition and strategy on your mindset and overall well-being? In this episode, we are joined by Laetitia Andrac, a strategy expert, author, and intuitive soul, who is on a mission to empower women leaders and entrepreneurs. She helps them create soul-aligned businesses and lives without the burnout. Laetitia, from Essential Shift, shares her profound experience, insights, and wisdom on how she integrates rituals and practices into her role as a 'business doula,' a woman, and a mother. Her journey towards cultivating a remarkably robust mindset has led to the creation of a thriving, conscious business and life that serves people, profit, and the planet. Laetitia's approach to weaving intuition and strategy into harmonious coexistence is nothing short of pivotal. Her insights are not only instrumental in personal growth but also in mindful entrepreneurship, revolutionising both business and life. Key Episode Takeaways: Find rituals and practices that align with your current life stage and can sustain your well-being. Nurture self-awareness and adopt a harmonious approach to life and business. View your goals as part of a bigger picture and regularly check how they make you feel. Reconnect with your intuition and inner wisdom to create a flourishing business and life. SHOW Show Resources: Follow Laetitia on Instagram - HERE Access Laetitia's Book - ‘Light It' - HERE Connect with Laetitia on LinkedIn - HERE Follow Emma, the Podcast Host on Instagram - HERE If you found this episode inspiring, remember to share it on your Instagram stories and tag us at @emmalagerlow About The Guest Laetitia Andrac is a strategy expert and intuitive soul who is passionate about helping women leaders & entrepreneurs in creating a soul aligned business, career & life without burning out. She is a ‘business doula' and founder of Essential Shift - a micro business consultancy agency based out of Cronulla Beach. With over fifteen years of strategy consulting, start-up mentoring and corporate leadership experience, Laetitia Andrac has led many successful growth and innovative programs in many high-profile global organisations, including Telstra, Deloitte, Doblin, Capgemini, Bloomberg Philanthropies and the French Government. She understands first-hand the daily juggle of successful entrepreneurs, which can leave them feeling triggered, time-poor, spread thin and burned out. Laetitia knows these problems too well, as she experienced burnout in 2014. At the time, wrapping her head around being burned out was impossible. People like her didn't burnout. This experience taught Laetitia the importance of reconnection with her intuition to avoid burnout. She shares that in her #1 best-selling book, LIGHT IT: How to Trust your Intuition and Build a Thriving Business, explaining her LIGHT framework. It has helped hundreds of entrepreneurs shift from burned-out to blissed-out, reconnecting them to their intuition and inner knowing. Laetitia's business and leadership experience is backed by extensive qualifications. She holds a Master of Science in Entrepreneurship and Strategy from a top-nine global business school, EM-Lyon. She holds an International Coaching Accreditation and is an expert in Reiki, Ayurveda, Meditation and Shamanism. Laetitia's clients value her unique way of combining intuition and strategy to find harmony and authenticity in how they grow their businesses and impact their communities. Her consulting business, Essential Shift™, is thriving and growing as she offers a unique approach to business and leadership. Her passion is to bring a sense of the sacred and intentionality to everyday life. She is a mother of two girls and lives in Cronulla Beach. She is attempting to practice what she teaches, coaches and mentors: creating a life that is aligned and sustainable. Join us on this journey to enhance your worth, wealth, and well-being. Your mindset matters, and anything is possible when you put your mind to it. With Love, Emma. X.

I loved EVERY moment of this podcast conversation and I can't wait for you to hear it! It was an honour to speak with Laetitia Andrac, Founder of Essential Shift, seasoned strategist and mentor with over fifteen years experience in strategy consulting, start-up guidance, and corporate leadership. Laetitia supports women to harness the power of their intuition and follow their inner voice in life and business

Rick Doblin, Ph.D., is the Founder & President of the Multidisciplinary Association for Psychedelic Studies (MAPS) and this episode is all about his life and work. This episode is a holistic look at the point where traditional therapy meets psychedelics and how Doblin and his team have spent the last few decades appealing to the scientific community and lawmakers across the world. Doblin gives us a fresh perspective on the mental health crisis discusses his studies & experiments in Iceland. We cover his early professional life and what lead him to pursue the science of alternative medicines. Doblin believes that with psychedelic assisted therapy, the world could be trauma free by 2070. Rick Doblin Links: MAPS - https://maps.org/about-maps/mission/ Get Involved - https://maps.org/take-action/ Instagram - https://www.instagram.com/rickdoblinphd/ Learn More - https://sprout.link/rickdoblinphd Please leave us a review on Apple & Spotify Podcasts. Vigilance Elite/Shawn Ryan Links: Website | Patreon | TikTok | Instagram Learn more about your ad choices. Visit podcastchoices.com/adchoices

Psychedelic revolution or schismogenesis? Robert Forte is basically the Forrest Gump of the psychedelic world. He's been in the gam with some of the biggest names in psychedelic history, Grav, Leary, Sholgren, Stamets, Doblin, the list goes on.  In this conversation Robert lays out one of my favorite things in the world, an alternate narrative to the one we've been presented around psychedelics. Robert presents us with a deep history of psychedelics as a weapon on the American public. Some of the players are surprises to me and I think you'll be as delighted as I was to hear the big name drop. The details are substantial, please dispel some disbelief and use your own discernment.    ORGANIFI GIVEAWAY Keep those reviews coming in! Please drop a dope review and include your IG/Twitter handle and we'll get together for some Organifi even faster moving forward.   Connect with Robert: Website: Altered States of America - Altered States of America.Substack   Books: "Entheogens And The Future of Religion" -Robert Forte Facebook: Robert Forte    Show Notes: "Brave New World" -Aldous Huxley  "The Creature of Jekyll Island" - G Edward Griffin  More Deadly than War - G Edward Griffin(youtube) "Acid Dreams" -Martin Lee  "The Beast Reawakens" Martin Lee Schismogenesis: The Generations of schisms, creation of division "Mary's Mosaic" -Peter Janney  President John F Kennedy's Peace Speech "The Immortality Key" -Brian C Muraresku "The Secret Teachings of All Ages" -Manly P Hall "Outside Looking In" -TC Boyle  "The Road To Eleusis" -Gordon Wassan, Albert Hofmann   Sponsors: Mark Bell's Mind Bullet This Kratom Extract supplement supports your cognition like no other and that's not just because Mark's a homie. Get some over at mindbullet.com and use “KKP” at checkout for 20% off! Ancestral Hunting School To learn many skills of survival and ancestral tradition, head over to ancestralhuntingschool.com, punch in “KKP” at checkout for 10% off! Cured Nutrition has a wide variety of stellar, naturally sourced, products. They're chock full of adaptogens and cannabinoids to optimize your meatsuit. You can get 20% off by heading over to www.curednutrition.com/KKP  using code “KKP” Lucy Go to lucy.co and use codeword “KKP” at Checkout to get 20% off the best nicotine gum in the game, or check out their lozenge. To Work With Kyle Kingsbury Podcast   Connect with Kyle: Fit For Service Academy App: Fit For Service App  Instagram: @livingwiththekingsburys - @gardenersofeden.earth  Odysee: odysee.com/@KyleKingsburypod  Youtube: Kyle Kingbury Podcast  Kyles website: www.kingsbu.com - Gardeners of Eden site    Like and subscribe to the podcast anywhere you can find podcasts. Leave a 5-star review and let me know what resonates or doesn't.

Larry Keeley is a renowned innovation scientist with over forty years of experience in the field. He co-founded Doblin, the leading global firm focused on enhancing innovation effectiveness, and has nurtured over 700 alumni through the organization. Keeley's contribution to academia is noteworthy. He has been a professor at the IIT Institute of Design for 39 years, a board member, and a leading employer of graduates. He also held a professorship at the Kellogg Graduate School of Management's MMM Program for 12 years, earning the title of Distinguished Professor in 2015. Throughout his academic career, he has helped educate over 5,900 Masters or PhD students as innovators, creating a robust global network of colleagues. Adding to his achievements, Keeley is the author of the #2 all-time best-selling book on innovation, "Ten Types of Innovation," which has been translated into 15 languages. His outstanding contributions to the field earned him recognition by BusinessWeek as one of the top seven global "gurus" of the innovation field, and one of the top 27 designers in the world. In 2021, the Bankinter Foundation in Spain appointed Keeley as the new director of their famed Future Trends Forum, which is conducted bi-annually in Madrid. Despite retiring as a Managing Director from Deloitte (the firm that now owns Doblin) in late 2020, Keeley continues his mission to advance the methods of innovation through research, currently with Keeley Innovations LLC. Keeley is a frequent lecturer on innovation at the Berkeley Haas Business School and an EY Luminary, where he works on cases and capabilities that are reshaping the field of innovation. His dedication and passion continue to have a profound impact on the innovation landscape. https://nexuspmg.com/

For access to the full Sus Psychedelics, Inc. series and other premium episodes, subscribe to the Al-Wara' Frequency at patreon.com/subliminaljihad. PHASE THREE: RUNNING THE SHOW Dimitri's high school experiences with 2C-B and MDMA, the synchronicity of the Hyphy/Thizz movement sprouting up in Alexander Shulgin's East Bay backyard, the extremely different vibes around drugs in 2005, Dimitri's 2009 documentary about suburban Thizz dealers in the Bay… The origins of the Multidisciplinary Association for Pyschedelic Studies (MAPS), “Early Therapeutic Use of MDMA, 1977-1985”, the Boston Group, Shulgin turning on Lt. Colonel Leo Zeff aka “The Secret Chief” to MDMA in 1977, ARUPA at Esalen, Jungian lay therapist Ann Shulgin, her theory that using MDMA helps you recognize the positive aspects of the totally selfish demon inside you, Chilean Dr. Claudio Naranjo and Sasha Shulgin's collaboration from 1962 onward, Jack Downing's Exuma Island Institute in the Bahamas, Dr. George Greer and his wife Requa Tolbert, Catholic priest Michael Clegg who began selling ecstasy in Dallas night clubs in 1983, Dr. Rick Ingrasci promoting MDMA therapy on Donahue in 1985, Tim Leary's former Harvard research partner Ralph Metzner, Doblin founding the Earth Metabolic Design Laboratories (EMDL) in 1984, Physical Abuse in MDMA-Assisted Psychotherapy, founding MAPS advisors Francesco Di Leo and Rick Ingrasci both losing their therapist licenses for having sex with patients during MDMA sessions… Background on Psychedelic godfather Alexander “Sasha” Shulgin, Shulgin's decades-long relationship with the DEA, his membership at Bohemian Grove, Shulgin's infamous bad vibes concoction STP/DOM, German pharma companies selling 2C-B aka “Nexus” in 1990s South Africa, PHASE FOUR: DIMITRI'S TRIP Dimitri reveals for the first time his journeys with “Gustavo”, a Peruvian shaman to the 0.01% in 2011, getting psyopped by ayahuasca utopianism, and which billionaires were secretly getting EnLiGhTeNeD years before the new corporadelic renaissance hit the mainstream.

"We are in a psychedelic renaissance with more psychedelic research than ever before with more than 400 psychedelic companies that have raised millions of dollars already" - Rick Doblin. This a fantastic Rick Doblin masterclass on psychedelic science, therapy and experience from a personal and business approach. In this conversation, Rick Doblin also explains the fundamental role of MAPS in drug reform, psychedelic-assisted treatment, and phase 3 for MDMA-assisted therapy approval. This a thoughtful, deep and transversal interview about the psychedelic landscape's power, impact, considerations and nuances.  "The biggest psychedelic risk is political." In this conversation, Rick and Isra cover much ground on psychedelics, from set & setting and preparation and integration to Rick's best practices, personal LSD, MDMA and psilocybin journeys and mystical experiences.  "When we dream, we enter into a psychedelic space. So start paying attention to your dreams one or two weeks before. The content of a psychedelic experience often moves to our dreams" - Rick Doblin. "In preparing a psychedelic experience, emphasize the necessity of doing it for human development." Rick Doblin, PhD in Public Policy, is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). "The more attention you put into preparation and integration, the deeper you can get into it" - Rick Doblin. Main interview topics Potential psychedelics risks and benefits. Rick Doblin's top life highlights. Rick's perfect set & setting for a psychedelic experience. How Rick Doblin addresses an ideal preparation process and integration afterwards for set & setting and integration and preparation. What motivated Rick to get himself into the psychedelic world? A tour through the evolution of psychedelics. What Rick has learned from founding MAPS. About the first study on MDMA (in Madrid!). The biggest takeaways from his first and last entheogenic experiences were. How we can make more conscious use of psychedelics. The essential learnings from interviewing Timothy Leary, Ram Dass, Hoffman, Tim Robbins… The most impactful discovery ever made by MAPS on psychedelics. Rick's take and personal experience on psilocybin and his predictions on adopting psilocybin as a medical and therapeutical tool. Rick's most meaningful psychedelic experience. His most effective skill for this world we live in and why. Rick's essential habits set for every day to thrive in? Other books that have influenced Rick Doblin the most and why. Rick's Doblin best practices for optimal mental health. Rick's mission in 2023 and beyond and The role of MAPS in today's world. Recommendations for someone looking to reconnect with themselves. Where people can learn more about current scientific studies into the therapeutic benefits of psychedelics. Psychedelic applications Rick finds most promising. Rapid-fire questions. Rick's parting thoughts. "Withdraw the projection of our shadow into others - psychedelics can help us to do that." Podcast show notes: Manifesting the Mind Rick Doblin's book. Psychedelic Science 2023. Drug Set & Setting book. The Way of Psychonaut. One Flew Over the Cuckoo's Nest - book. Realms of the Human Unconscious: Observations from LSD Research - book. MAPS website. Island - Book The Glass Bead Game - book. The Treatment Manual - MAPS (free download) Clinicaltrails.gov Descending The Mountain - film. Acid test - book. How To Change your Mind - Documentary. 40-day Microdosing LSD experiment. 52-day macrodosing Psilocybin experiment. Psilocybin Spanish platform. Dennis McKenna interview. Jules Evans interview about psychedelics and philosophy. Paul Austin interview on microdosing. "You can use science to understand the mystic experience of connection."

“I know it's hard for people to think about holding on if they're in despair, but there's the possibility of healing coming ahead. Don't give up hope,” says Dr. Rick Doblin, who has devoted his career to getting MDMA and other psychedelics approved by the FDA.  As you'll hear in this episode of Raise the Line, he could be on the verge of seeing his decades-long dream come true.  On the day host Shiv Gaglani spoke to Doblin (January 5, 2023) successful results from a Phase 3 clinical trial of MDMA to treat PTSD were released by the Multidisciplinary Association for Psychedelic Studies – an organization Doblin founded thirty-six years ago. This sets in motion a process that could result in FDA approval of MDMA for this use in 2024. That's very good news for the millions of Americans with PTSD – and hundreds of millions worldwide – whose disease is resistant to other treatments. One of the next big steps is training therapists to incorporate these drugs into their work, something MAPS and other organizations are moving quickly to accomplish. Tune into this fascinating conversation about the political and social factors that have held up legalization of psychedelics for decades, other promising applications of MDMA, what fuels Doblin's passion for normalizing the use of these promising medications, and the largest ever conference on psychedelics coming to Denver, Colorado in June.  Mentioned in this episode:https://maps.org/https://psychedelicscience.org/

When you look at the world, it can feel like we're in a precarious moment. If you've listened to past episodes, you know we call this the meta-crisis — an era of overlapping and interconnected crises like climate change, polarization, and the rise of decentralized technologies like synthetic biology. It can feel like we're on a path to destroy ourselves.That's why we're talking to Rick Doblin, the founder and executive director of the Multidisciplinary Association for Psychedelic Studies, or MAPS. They're a nonprofit focused on educating and researching the benefits of using psychedelic therapy to address PTSD and promote humane ways of relating worldwide.Doblin's vision is for nothing less than a transformation of society through psychedelic-assisted therapy – not for the drugs themselves, but for their ability to help us react to one another with compassion, appreciate differences, and accept criticism.Given the perma-crisis we face, it's provocative to think about a tool that, when prescribed and used safely, could help us overcome rivalrous dynamics out in the world and on social media. If we rescue our hijacked brains, we can heal from the constant trauma inflation we get online, and shrink the perception gap that splits us into tribes.Both MAPS and Center for Humane Technology want to understand what helps minds heal and be free. We invite you to keep an open mind about a different kind of humane technology as you listen to this episode. Correction: Doblin attributes a quote to Stan Grof about psychedelics helping your ego be “transparent to the transcendent.” In his book Pathways to Bliss, Joseph Campbell wrote, "When a deity serves as a model for you, your life becomes transparent to the transcendent as long as you realize the inspiring power of that deity. This means living not in the name of worldly success and achievement, but rather in the name of the transcendent, letting the energy manifest through you.” Grof was likely paraphrasing Campbell's work and applying it to psychedelics. Additional credits:The episode contains an original musical composition by Jeff Sudakin. Used with permission. RECOMMENDED MEDIA Multidisciplinary Association for Psychedelic Studies (MAPS)The non-profit founded by Rick Doblin in 1986 focused on developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. MAPS has some open clinical trials; see details on their website. Rick Doblin's TED talkIn this fascinating dive into the science of psychedelics, Doblin explains how drugs like LSD, psilocybin and MDMA affect your brain - and shows how, when paired with psychotherapy, they could change the way we treat PTSD, depression, substance abuse and more.How to Change Your Mind by Michael PollanPollan writes of his own consciousness-expanding experiments with psychedelic drugs, and makes the case for why shaking up the brain's old habits could be therapeutic for people facing addiction, depression, or death.How to Change Your Mind on NetflixThe docuseries version of Pollan's bookBreath by James NestorThis popular science book provides a historical, scientific and personal account of breathing, with special focus on the differences between mouth breathing and nasal breathing.Insight timerA free app for sleep, anxiety, and stress RECOMMENDED YUA EPISODES You Will Never Breathe the Same Again with James Nestorhttps://www.humanetech.com/podcast/38-you-will-never-breathe-the-same-againTwo Million Years in Two Hours: A Conversation with Yuval Noah Harari https://www.humanetech.com/podcast/28-two-million-years-in-two-hours-a-conversation-with-yuval-noah-harariYour Undivided Attention is produced by the Center for Humane Technology. Follow us on Twitter: @HumaneTech_ 

Welcome to the first ever Psychedelic Sunday episode! There is a lot of overlap between cannabinoid and psychedelic experiences and today we launch our coverage of the psychedelics industry. Challenges and opportunities within psychedelics; highlighting four stocks: Compass Pathways (NASDAQ:CMPS), Cybin (NYSE:CYBN), Atai Life Sciences (NASDAQ:ATAI), and MindMed (NASDAQ:MNMD).

Rick Doblin is an American entrepreneur, philosopher and psychedelic advocate. Doblin is the founder of the Multidisciplinary Association for Psychedelic Studies (MAPS), which is the leading organisation in the world supporting research into the therapeutic potential of psychedelic drugs.

Lexman was talking about the interview he did with Rick Doblin. He mentioned that Doblin is a great guest and has a lot of knowledge about psychedelics. Doblin talked about his experiences with psychedelics, and how they have changed his life for the better.

Prosegue il viaggio stupefacente nella Summer Edition 2022 di Stupefatti.Seguendo il "filo rosso" tracciato dal nuovissimo documentario Netflix, intitolato "Come cambiare la tua Mente", oggi raccontiamo le mille battaglie di Rick Doblin, fondatore di MAPS, colui che per oltre trent'anni ha organizzato e finanziato la battaglia antiproibizionista col fine di rendere gli psichedelici nuovamente disponibili alla scienza e alla medicina. Una vita incredibile, passata a raccogliere fondi, smontare le bugie propagandistiche del proibizionismo e fare lobbying parlamentare per perorare la causa degli psichedelici.Armatevi di ghiacciolo e schiacciate play!Note dell'episodio: - Il documentario Netflix "Come cambiare la tua Mente": https://bit.ly/3oTXi0X- Acquista il libro di A. Shulgin "Pihkal: a Chemical love story": https://amzn.to/3vPvZZu- Acquista il libro di Albert Hofmann "LSD: il mio bambino difficile": https://amzn.to/3AdNOEo- Acquista il libro di Pollan da cui è tratto il documentario: https://amzn.to/3vF6CK1Entra in contatto con noi usando la mail stupefatticast@gmail.com o seguendo su Instagram il @stupefatti_podcast!

Geoff Tuff is a principal of Deloitte Consulting LLP and holds various leadership positions across its Sustainability, Innovation, and Strategy practices. In the past, he led Doblin, the firm's innovation practice, and was a senior partner at Monitor Group, serving as a member of its global Board of Directors before the company was acquired by Deloitte. He has been with some form of Monitor for close to 30 years.Steve Goldbach is a principal at Deloitte as well, and serves as the firm's chief strategy officer. Steve helps executives and their teams transform their organizations by making challenging and pragmatic strategy choices in the face of uncertainty. Over a 25+ year career, Steve has served clients across most industries, with an emphasis on industries in transition and consumer-driven sectors.Steve and Geoff co authored “Detonate: Why - And How - Corporations Must Blow Up Best Practices” and “Provoke: How Leaders Shape the Future by Overcoming Fatal Human Flaws.”They join Greg to discuss these books, their “provocative” work, questioning orthodoxies, balance, and shaking up the traditional career path.Episode Quotes:Steve Goldbach: How the traditional “career path” is changing36:14 - The problem is that if you believe that we're in a world that will require constant evolution, then that career path isn't worth the paper it's written on, because things are gonna change substantially over the next while. So I think the moral contract between organizations and their people needs to be rethought. Instead of saying it's about achieving a particular level the next X years, it's gotta be achieving a particular set of skills, akin to the kind of skills that are going to be relevant in the marketplace. Geoff Tuff: How did we get to a place where change is not common in a workplace?12:39 - We as human beings tend to place a higher prominence on data and information that is more readily available versus data and information that's more difficult to get. And because of that, we kind of assume that the information we have around us all the time is the right information that we need to be using to make decisions. And therefore opening up the information for challenge, we're opening up one's logic to challenge, it feels antithetical to making good efficient decisions. And that's just one example of both individual and organizational biases that we think work together as a system to prevent change.Geoff Tuff: Best practices & orthodoxies05:08 - We are now living through, Steve and I believe, a time where we're shifting from a world that's governed primarily by linear change to one that's increasingly governed by exponential change. And with that comes a different set of operating rules, where the old playbooks just don't apply. The only way we can break the habits of operating by rote, using the playbooks, is to get people to recognize when they're being impacted by orthodoxy, meaning just the kind of conventional wisdom of the way the place operates.Show Links:Guest Profile:Geoff Tuff's Professional Profile at Deloitte Consulting LLPGeoff Tuff on LinkedInGeoff Tuff on TwitterSteve Goldbach's Professional Profile at Deloitte Consulting LLPSteve Goldbach on LinkedInSteve Goldbach on TwitterTheir Works:Provoke: How Leaders Shape the Future by Overcoming Fatal Human FlawsDetonate: Why - And How - Corporations Must Blow Up Best Practices (and bring a beginner's mind) To Survive

Theme: How many to mint?  Best to buy with conviction & mint more than 1Gives option to sell while staying in project Can help remove some of the emotion of decision Gives chance to mint/sell “rares” to help pay back mint costs Better to pass on mediocre projects & those with poor risk/reward, save for good projects Free mints?    Affordable project: Flower Fam    (thanks Myth47.eth) https://opensea.io/collection/flowerfam-fam-official https://www.flowerfam.earth/ NFT News NFT Headlines: Goblintown Is a $37M NFT Collection That No One Can Explain - CNET  Nike's RTFKT Just Bought DotSwoosh Ethereum Domain Name  Solana's blockchain clock loses track of time, now running 30 minutes behindReliably unreliable: Solana price dives after latest network outage   Bug Brings Down Solana Blockchain for Four Hours - Decrypt  LUNA Reboot Plummets Over 70% Just Hours After Debut - Decrypt  Transcript:   [00:00:00] Today on all about affordable NFTs. We're asking the fundamental question. How many should I mint? 1, 2, 3. All right. I don't want to spoil it. No spoilers. We'll let you know exactly how many demands, the exact number. You know, you can use this formula any time. No. Okay. Now that we've over promised on that one, what are you seeing in the news? [00:00:23] All right. What are we seeing out here? Oh man, goblin town, this, this, and if the collection has sadly taken over the space and it's not just this one. So goblin town is, is kind of a, a term used for bear markets. This collection dropped at just the right time. It was a free mint. I believe last I looked, it was up at seven and a half feet or so. [00:00:44] Uh, it's insane. What this is doing there's they've had some, I don't know if it's just Twitter spaces or. Uh, you know, clubhouse or whatever that they're just, it's like six hours of people making these Doblin sounds. I don't know what's going on. There's a ton of knockoff collections similar to this. [00:01:06] It's all over the place on the leaderboards of a volume right now. There's just, I don't know. This is what everybody's turned to because you know, people can't turn away. Even in a bear market, they got to find something and I don't own any of this stuff. It's fun to watch a, I I'm glad people are having fun. [00:01:24] I'm glad some people have made some serious, easier, you know, be careful a little. So, you know, this is, this is also where you can get burned really fast. Yeah. I mean, in the seven day, look on crypto slam. I see goblin town, like second to board ape, which is just impressive in terms of overall sales volume. [00:01:41] If we're talking about sales volume, just like number of, uh, things change in hands, you know, overall, the overall marketplace for NFTs in the past week is like down seven, 8%. I think, remember our adage here, the faster it rises, the faster it falls. Right? That sort of the thing that burns brightest burns briefly. [00:01:58] So I don't think we need to talk anybody out of not buying this. So don't worry. You have one of these and you've got it for free. You should sell this. Okay. This is financial advice. We don't get funny. That is financial freaking. That? No. So we're why are we saying, uh, certainly like, remember moon birds that went up very, very quickly, but it had an established docs team. [00:02:25] This isn't like, nobody knows who the person is like, so, okay. Could be anybody. And guess what? Usually people have chosen to be, uh, anonymous for a reason as we have begun to find out time and time and time and time again. So that is a huge factor. Again, the speed at which bitch it went up. And then also I'll just be honest, like you overall art, not there. [00:02:48] Uh, the community is funny. I will say that meme community is real means are like, it's not a joke. Well, it is a joke, but it's not a joke. And how much the value bedded and imbued in it is as anyone who has ever seen Elan wax poetic about [00:03:04] Elan news. We're not going there today. Now we can skip it on for, he doesn't do too much in an empty. Now. All right. But yeah. Well, so we'll move on to the next story here. We've been talking a little bit about a theory from, uh, ENS names and we just saw that artifact, uh, recently purchased by Nike. They scooped up the dot sploosh dot Ethan name for 19.72 E. [00:03:30] Uh, homage to the, uh, the founding year of Nike get that's 20 that's about $35,000 at the time. Uh, you know, it's moving quickly up down. So I w you know, who knows what it is while you're listening to this, but yeah, that's some serious eat their congrats to the seller who, who thought to, to get the dots, woosh dot neath. [00:03:49] I mean, that's not even smoosh daddy. That is dots. Daddy for 28. So ENS names are hot. Yeah, I just, I don't understand how you find the seller for these things. How do people end up finding them? But that it's good to see, you know, that's, that's some serious adoption. I mean, we had that, we were talking about sort of the per usual, remember the, the, the domains with, uh, the numbers, the three number domains that daddy, if it's like, that's been on the like absurd rise. [00:04:20] It's it's worth. If you're, if you're looking out there, we set it in the previous one. We don't know how to make it an affordable project, but daddy's names are affordable, wildly affordable. So if you want to go speculate, the problem is you have to speculate on a lot of them. Cause if you're buying, what is it? [00:04:32] swoosh.dot dot swoosh, Dottie. Like it's an absurd thing that just happened to land on the branding. Bingo coin of it. But you know, there's, there's still a lot of names out there. If, uh, if you're out there, I mean, you can fish, you can fish, but yeah. And then you get to do one by one. I've definitely spent some time looking for different things. [00:04:55] A lot of dead ends. So you gotta be patient looking for, for the right name. Well, what's your approach to that? I mean, not giving away your secrets, just you look around and variously. Think about it. I end up doing it forever and then realized. My great fines are not actually very good finance at all. I think. [00:05:13] And I've registered a few, but yeah, thinking of trying, trying to think of like domain names and, you know, then didn't see the whole four digit number coming, or I think all the five digits are gone and I'm sure all five digits are gone at this point. That's only 10 K so we know how fast those go. I'm sure. [00:05:30] You know, I'm sure, you know, the numbers have been popular, but I still can't imagine that there's somebody just flipping, you know, 7 3 9 1 2, 4. You know, each day, you know, all these numbers. I think it's hard to understand how you know, how to find all of these different numbers in the end, but, you know, strong names are definitely going to be a good play here. [00:05:54] I just tried to get 8, 6, 7, 5. Jenny, can I turn to you? Definitely not a Dottie to dress buddy's already burned to. All right. And you know, maybe we should move on to the next one because we're seeing how strong, what it means to have an ENS name. That is an Ethereum name. Of course. Now we've talked a bit about Solana we've. [00:06:14] Uh, I think George finally was able to buy into a project. We had a couple instances recently of Solano, some bugs with the chain. One was that it was. It was down by, or is running behind for 30 minutes. Then the, uh, the whole chain just went down for another four hours. This isn't, this isn't that unusual, unfortunately. [00:06:38] And it is one of the security risks that we talk about, like going to, uh, many of these other alt layer ones, those being non Ethereum layer ones. Yeah, it drops the price of Solano also kind of tanked like 14%, who knows why, but probably not, not because it seems to break on a weekly basis for multiple hours, which is, you know, the antithesis to reliable. [00:07:03] And what's more when that drops. So to does any underlying, you know, NFT that you have on, on the platform, right? I don't know. I really I'm trying not to be such a hater and I, that's why I bought my, I have my see fish. What is it? See society, fish. I bought we posted in a reason, one, so disclosure, I have one of those cool analytics behind that. [00:07:27] You know, I'm hopeful for the platform overall, but like, it's just, you know, you got to have a platform that's reliable enough to stay up and instill confidence. And if it doesn't, there's a lot of downstream negative. And along those same lines, we've got another headline here. There is a new Luna chain that was launched a Luna 2.0, it crashed immediately. [00:07:48] I think it was over, down over 70% right away. I think it is close to dead again. So, you know, kind of saw that one coming who's that. People weren't putting much into that. I assume it was people just getting airdrops and then immediately selling. But yeah, let's be careful getting into, to any other of these new chains that aren't tried and tested. [00:08:12] No trust, no token. And really it's just, you know, it just serves as another sad headline here. Hopefully some of the people that I got just completely run, run over and the last one got a little bit of, uh, an ability to recoup some of that. But again, you know, can, can we just stop creating these unstable coins and these these pieces have just hurt the market now? [00:08:38] Well, yeah, I think that's it for a headline. So let's move on to our affordable project, which. When George is going to talk about today, it wasn't his originally. Tell us about this, George. All right. I have to, I'm not sure if I'm going to reserve. Thanks, but good old myth. 47 dot east, uh, in our, in our discord has been talking about flour. [00:09:03] It's not that myth. 47. Hey, there's Keith address the names? Like what about name and then number, name, and number. All right. Let's park that in the back. We'll have a brainstorm later. Myth, thank you for bringing this and also keeping up the trend, uh, and really what this is. It's a, it's a game, it's a staking game. [00:09:22] Uh, and it's on it's on a theorem, these funny looking flowers, the flower fam, where you can get the, uh, project, right. Flower fam flower fam. Yeah. And we have the Lincoln here and essentially what you can then do. Currently like the floor is at 0.1, three, three decent activity around it. But like, it was only about 12% of them open for sale because 88% of them are staked and they're staked because when you stake them, you can earn what's called Huntington's. [00:09:54] So you stake your JPEG and then you earn yield on that. So a classic sort of yield play here. You can save up that honey coin and then buy things like a B, or the ability to attract, to be things that would then accelerate your staking rate. They've got land plans, other drops planned. It is a pretty robust discord. [00:10:13] And so far the honey USD is holding up. But I think the play here full disclosure, I, you know, I love rollercoaster. So I jumped on this one. Is to, uh, to take a look at it and, you know, try staking a fire if you want to get in on it. But also keep in mind, you know, the I'm making $4 a day. So I will I'll, I've made my money back, all things considered in a couple months. [00:10:37] So I don't know. Uh, but here's the thing. These types of dynamics work completely fine. Right? The defy game dynamic is fine until it's not fine. When the music stops number drops pretty quickly. And I've been saying this in the discord. So I I'm in this, but also have sort of flashbacks to Peggy exi, where it was fine when all of these guilds were jumping in and buying new assets in the marketplace. [00:11:04] This is very important. The money must come from somewhere. Right. That coin is supported because people are buying it like me. I just spent money in to play this game. They get a percentage of that that goes into the economy. They're going to launch new flowers, secondary market, as long as people are buying and you see new people coming in, you're fine. [00:11:24] Once that stops and profit taking starts, right. Everyone has upgraded to a certain level and they start to say, oh, I don't care about yielding that much more. I care about cashing out and you can look at these flows on contract and whatnot. Once the amount of sort of minted honey is being superseded by the spent money, the spend meaning things that are transferred out of the ecosystem. [00:11:47] Once that inverted. Number drops fast. I actually thought it was a lot longer window for when that would happen. And I thought that would Peggy assay. I took back my initial, my initial amount pretty early, but then I kind of like, oh, every best. I thought it would last a few months, even at inverted. It doesn't when it drops, it drops quickly. [00:12:04] Cause there's not enough market volume volume in terms of the number of holders of the actual coin to sustain a price selling pressure, which will again, drop quickly. So here's the. Absolutely not financial advice, but if you are going to get into it, monitor that. And as soon as you can you take out your winnings, you take in what you were, you know, spent a play with it, and then you're much safer playing. [00:12:30] And be wary of doubling down when you're at or nearing top of this because you're juggling knives. And so there's the full disclosure. It's a cute looking game. Well-built, I'm very impressed with the technical elements so far, it's easy to use. So Bravo to that, leaderboards, whatnot, cute looking flower. [00:12:48] I'm going to try to get a B I'm sure I'm going to get, I'm going to make mistakes. Even after I said this I'm going to hold too long. I guarantee it. [00:12:55] All right. Yeah. I think you were right in describing this as a rollercoaster. Ups and downs. And remember that rollercoasters take a lot longer to go up than they do to come down. But yet he, you seem to be a sucker for a rollercoaster ride and just remember to get off the rollercoaster, they don't keep going. [00:13:12] Nothing good happens to ride the roller coaster too long. Good. I'm going to send me back to run it, run it again. I'll say, do you have also, do you have some Thai food? I just want to gobble down a whole bunch of Thai food here. I'm just super hungry. Some of them settled. Whatever right. Well, thank you for bringing that one to us. [00:13:32] Myth 47 and George for talking about that, I think we'll move on to our topic here. How many Timmins knit them? All right. Let's just mint the ball, all the things, all the things. I think in a previous episode, we talked about sort of when you have conviction, get more than one, so you can hold one, sell one in this classic, like, all right. [00:13:50] I paid for what I got in four and I think that's fine advice. However, There's a nuance to it, depending on what, you know, what the base price is and what your appetite is for being able to afford that. So I've seen, you know, recently we talked about, I had an opportunity to admit to us Nazis and I, and I didn't, I think, you know, it was 0.1. [00:14:12] I was like, eh, I had medium conviction and now looking back, I'm like, I wish I got to, however, there's others that went to junk and I'm like, glad I didn't get. Yeah, I think that's a good point. I think, you know, we've talked a lot about, you know, weighing the risk and reward of, of these and, you know, I think it's worth thinking a little bit of like, what is the worst case here? [00:14:33] What do you think the floor could be? And if we're, and if we're thinking at about, you know, with, for me, the OSA NACI one was, was a smart play because I felt like it was a pretty low low risk that didn't. It was minting relatively quickly, a lot of good collectors. And he's a known collector. No on-site and an artist in the space. [00:14:53] And it's felt like a low relatively low risk. You know, I thought that it could hang around 0.1 to 0.2 for quite a long or even the I'm sorry, even like 0.07 to 0.15, more like that for a time that it's risen pretty quickly to, I think it's around 0.4 right now. And certainly gone faster than I thought, but it's, I've thought about this a lot more and trying to, trying to wait for those types of plays, where I see a little bit lower risk. [00:15:23] And, and when I do see that putting. Uh, you're missing a couple more because it does give you the opportunity. I mean, there's a confused things that it does. One is it gives you the opportunity to potentially mint something, especially rare. You know, when you're thinking, when you're minting, you're getting it at that, you know, the original price. [00:15:39] And you do have the chance of getting something rare. So there, you know, if you believe in the project and you think that it's worth. That 0.1 or whatever the mid price is, you know, theoretically a rare piece from that collection should be worth, you know, some percentage more than that, a mid price. So each mint has a little bit more value and if you do it enough, you will get one of those. [00:16:01] But the other thing is, is that you can, you can pick what you want to hold on to. You can also, like you said, George sell without being out of the collection. I find that it removes a lot of the emotion to me about. Whether I want to sell a piece and maybe end up with nothing in the collection I'm able to sell, maybe recoup, you know, maybe even if you meant three, you know, maybe you can sell one, two or sorry. [00:16:27] Maybe you can even sell to two that you paid for everything. Like you were alluding to, uh, with the flower Fran project, you know, and take your perk of, take what you put in out and then still be able to, to stay in the project and. Not feel like you maybe made a big mistake and, you know, watch it go up and don't feel like you get to be a part of it. [00:16:46] So here's the contrarian view to this though, is that 95% of projects that go through a mint end up with a price that happens below the floor. They just don't make it back. I'm also one to say, like I kind of buy and then I kind of wait and look at it. I'm like, Hmm. Did ya? So I think there are times where I'll get in on a mint, but then watch and wait and say like, all right, what's happening. [00:17:10] So for instance, you know, we're, we're kind of looking at it now. And the, the ex copy that we got is down to 0.6, seven that's X copy. So I would say that if you had time that, well, you could have sold one for. I know over 1.5 each and you know, I should have done that. Cause as, as I did live on the podcast, I meant that to did not mean to you, you know, I'm sure if I did been to, you know, what I should've done was sell on once that price got up to at least one and a half you know, I think that's, that's, that's what I try to do a lot more now and trying to be more conscious of taking some profit to cover the mid. [00:17:54] At the beginning, I would say that there's generally I, you know, yes, you're right. That a lot of, most of the time projects mint out in the floor price ends up below the mid price. I think there's often if you're picking the right projects, there's often a little exuberance around a mid doubt and The potential to, to, to sell something for over the mid price at that point, you know, it's not obviously for all projects, you know, you want to be picking the right projects, you know, and that's something that I think is easier said than done, but at the same time, it's. [00:18:29] Wedding, some things passed by if you don't have much conviction. You know, if you think that there it's a high risk, if you could give it, doesn't seem crazy that the floor price might be half the mid price. You know, if that seems to be feasible, you know, that's not, that's not great. For me to want to get into something, I wouldn't have real high conviction then if that's my prediction for it. [00:18:50] Yeah, again, easier said than done to actually to know that, but if you're, if you're looking at these things, you can generally get some sense of how fast it's minting. I, if I think it's going to. Mint out anyway. I'll probably, then I see that it's moving with some of the art blocks things recently that I talked about in the last episode I've been kind of waiting until there's about 30% minted at a, at a decent pace and see like, all right, this is, this is moving fast enough that I. [00:19:18] This is the lowest price and people are buying it. I don't think that it will take all that long to sell out. And I don't want to have a gas war and hopefully convince maybe two or three of those before it goes and get to choose something. You know, it's different with different collections. We've had, you know, we've talked about things that are pre reveal. [00:19:34] Pre reveal often is a great time to sell sort of before, you know, people buying. Unscratched lottery tickets, not sure what they are. You know, that is often a great time to sell. We saw recently a project that we're talking about in the discord record guy, we actually saw that those went higher after the reveal. [00:19:54] That's pretty unusual, but. And I think when you do have one that you're buying CRE reveal, it's, it's, that's one where it's worth selling. At least if you have a couple of words, selling something pre reveal and maybe holding if you want to play that game to see if you get something else, but not so bad to be able to take some, some profit before you know, before finding out if the practice is going north or south after the, uh, after that point. [00:20:18] Yeah. The, the other thing is like, if it's a Freeman, obviously max out what you can meant. No question. Right? Come on goblin town, goblin. You said it yourself, especially in a market like this. What I like is the confidence of saying like on the free mint, clearly the, the founders are saying like, we are going to get secondary gone. [00:20:36] Right? This is interesting. So you're saying free mint. You should meet more. Mint as many as you possibly can and frame it, like, I dunno, right? Like get yourself. Yeah. Obviously watch that gas, you know? We've had some, that's a low gas recently, although I have noticed some with that a lot more spikes days, weird days. [00:20:55] Very weird. It hasn't been as, I don't know, it's been quiet in the space, but. I don't know, I guess this has goblin town, right? So the, I want to come back to, because I was holding the point of the reveal, right? This game of the reveal of like, oh my gosh, excitement is coming. So I sold pre reveal on wrecked guy and I, you know, I made money. [00:21:17] Look, it was a free drop. So if you're one of our affordable projects was Deakin's amazing. Pick by India. What a great community. We've talked about it. That then give you a free drop four wrecked guy, wrecked guy pumps to like over and ease. Well over. I think it's down to like 0.6 0.7 now are supposed to reveal, but there was, there was a high point. [00:21:38] I made him, I made an error by selling before the reveal and in my mind, here's the. I did you make an error? No, I didn't make an error. I made half an hour is what I made. Right. That's what I most times that's the problem, right? It's an end of one, but my thinking is that the average sort of distribution for the overall resulting reveal, meaning that like we can't tell a certain image and then the owner just. [00:22:09] Changes the URL and each one has its own image. You're like, oh, this is the 1% rare. Oh, I'm in the 90%. Not rare that technically should be if the market's price right. And average emiratisation across the entire collection. So you move from this, like, am I going to get the one one-on-one 100 or do I want to get my smooth out average value right now? [00:22:29] And I'm like, I'll take the average value. And maybe that was, you know, I could've made more if I waited, I think most of the time though, there's hype, there's interests. There's people that want to play that lottery game. Cause they're like, oh, one of these could be worth 10 X the rest. And you're like, yes. [00:22:44] However, you know, what game, what game do you wanna play? If I had to, that would have been a great thing, but I didn't have the power to do. Yeah. So I think that's a case where, you know, it would be nice to have two, those were, I think they were just actually per wallet that they were given out, uh, for DJs holders. [00:23:01] So I don't really, I mean, it would be hard to have the, have gotten more than one unless you had multiple wallets, uh, holding them. So, yeah, that's a tough one, uh, for this many, you know, this discussion of how many to mint and I think you can actually apply. This idea to how many to buy when you're able to buy something at a low price, if you aren't going into it. [00:23:19] And you know, think that it's about the low as it's going to go. You know, it may be worth getting more than one, but you know, you never know. It's more looking at, you know, what a most people gotten into to the project that where most people willing to sell. And, you know, I think you can sort of learn. [00:23:36] That if you look at the activity for some time, uh, one project that George mentioned recently is the act guitars. And I've, I've been watching that activity a lot and that's just been it. Hasn't been looking for it to get down to 0.6 or so, and it won't get below point. 8.67. And even then it's just one or two, they're sticking at 0.7 and that's when we're, you know, I start to see after a while it starts to look a little bit more in tasting at that price range. [00:24:04] When you just see that anything that gets much below that is getting snapped up pretty quickly. But it's also one where, uh, they're cool pieces and. I would want it to have more than one in the end if I could, because I think that there's a good chance that they, uh, you know, that they could catch on at some point. [00:24:22] And I would hate, I would like to be right and like to stay in the collection. You know, if that, if that does happen, like, like when I say right to be right with, uh, being able to take some profits. Yeah. Because you want to hold it, I guess I'm getting a little less diamond handsy with some of my projects at this point. [00:24:41] I think. The larger sort of upside I've lost out on. And it's like thinking I have to like, hold these things forever. Like you can always get back into the project, frankly, like the chance that you were like happened to be holding, like the one thing that's going to go wrong. Uh, so I've, uh, I've begun to be getting back to our episode about head and shoulders, right? [00:24:59] Like I'm aiming for like the, the, the shoulders and knees, I should say. I'm like, I'm fine taking a profit where it is so that I can find another project, but the, the by twos is really if you're able to, especially for a smaller level, uh, the way to go and, you know, the larger, it gets larger, it can false. [00:25:18] That's where I get that. Yeah. I mean, right now, you know, executors are certainly. I dunno in the affordable range necessarily. It's it's, you know, for that, it's more that you start to see, you start to see that there is demand at a, at a slightly lower price, I guess, you know, but that's, that's one where it's a little harder like here's what I'm going to do. [00:25:39] Here's what I do. So by the way, flower fam the team, I forgot to mention not fully doxed. So lot of, a lot of great signals here. Uh, here's what I think is going to happen. There's going to be increased attention and then pressure. Cause everyone's staking their flight. As soon as the flower fam that price gets close to , I'm going to sell my flour and go get a, go get an Acura tar. [00:25:59] All right. And if that's my play, this is not financial advice. I'm talking about getting one JPEG for another gift back. All right. I like it. I like those avatars. You know, that's when we're, it would be tough to ship to a, get a couple of them necessarily. But, you know, I think that's the right to have the idea that you don't need to be diamond handed about these things. [00:26:19] It's not, you know, this, isn't the case of one project that's gonna take you to, you know, to board a planned at this point. You know, there's a lot of options out there and chances are that there's gonna, that they're going to have some success. And that it's going to reach it. You know, it's going to plateau or it's going to move along slowly. [00:26:37] At some point you had another note here in our, in our show notes that I really want to touch on and it's better to pass on mediocre projects. And with the poor risk reward profile. And save for good projects. You know, we are, you know, we had our shopping list. We're talking about guitars were, you know, bringing up these other, other projects along the way. [00:26:58] And I think it's getting easier to separate the wheat from the chaff. And while you can run around and try to find the next goblin town and bet on every single mean, like by the way, get on whatever free mint you can find do it. If that's your hustle, it's a fine game. Right. You've spent paying gas to be in the game. [00:27:15] Okay. But I think saving up and then really looking for quality projects as a play on levered leaf is, is what I'm looking at still. And I, you know, I don't think entities are going anywhere. Yeah, I agree. And that, that's good to mention that point that I mentioned that I had written there. Just, I think there's a lot of, I don't know, there's a lot of projects that are on sale for people that are going to be around the space. [00:27:40] For a long time and worth looking at those rather than hoping to catch the new lightning in a bottle or, you know, goblin town. And I mean, obviously if it's free, go for it, don't go, you know, don't go giving away your Eve and hoping that your, that it's going to turn into Maurice. Oh, and the, and the project I can never say no to. [00:27:58] I picked up another moon cat, speaking of which they fell below my buy price. I got a little orange tip. Well, smiling, happy fellows. That's a good one. And that's some it's all me. I was like, all right, what do we got here? Wait a minute. It's orange. That's rare. There's a clear face. That's good. It's happy. [00:28:13] Which seems to be they're more frownies than happies. So I got a smiling orange Tabby ready for action for under 0.3 and I waited patiently and just check it's just so much more relaxed time to be trying to. You know, even to, to projects that, yeah, it is nice to be able to, to shop a little bit more, kind of wait it out. [00:28:36] You know, it's hard at times to be patient as a buyer, but I do feel like it's easier when you realize that there's a bunch of different collections that are worth watching, putting on a list and then just be patient. Wait. I know for me, I'm trying to wait for offers to come through for the most part, unless I see something. [00:28:54] That's very mispriced. Yeah. I've been less on the offer and more on the like watching and knowing enough about a project to wait for that in this price. And I'm always looking at the recent activity to be like, all right, where's been the most like lowest low, so not the floor, but the, like the, who got desperate at one point and drop something. [00:29:14] Yeah, I should actually say I've been more, I've been using offers more often when I've already got pieces of a collection offering at a significant discount. And that's the intention is either I end up with it at a discount or maybe it, uh, you know, gets inspires somebody else to go buy it ahead of that. [00:29:34] Or at least make an offer ahead of that. You know, either way I'd be happy as far as someone picking up another piece from the collection or ending up with it at a discount. Alright, good topic. Good theme. See out there, join the discord. Remember none of this is financial advice and leave us a review so we can build up that massive audience so we can avoid insider trading. [00:29:57] That's right. Yeah.  

El no mejorar de manera constantemente los procesos conocidos, es una de las rutas más seguras al fracaso. Desafortunadamente, demasiadas empresas solo hacen innovaciones simples. En los mercados y la competencia de hoy, las innovaciones simples por sí solas nunca son suficientes para el éxito a largo plazo. Pueden construir una ventaja sobre la competencia, pero no crean las empresas, marcas o plataformas que nos emocionan.Con información de Doblin.Puedes dejarme tus comentarios aquí:Encontrarme en redes sociales como @ptorresmx Y si te interesan estos contenidos, puedes suscribirte aquí:Gracias por escucharme. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit ptorresmx.substack.com

On this solo episode of Virtual Coffee, I continued our "Featured Framework" series by showcasing the Ten Types of Innovation. Ten Types is a framework that was introduced to the world by Doblin, a global innovation firm. This frameworks helps you look at industry trends to understand how companies are innovating, and, in turn, you can identify innovation gaps that you, your business, and/or your product or service can fulfill. This is an impactful framework that is fun to dive into. Enjoy this introduction to Ten Types, and happy listening! Doblin's Ten Types of Innovation website ----more---- ☕️ Instagram & Facebook: @virtualcoffeepodcast ☕️ Email: virtualcoffeepodcast@gmail.com  ☕️ Linktree ----more---- ⭐️⭐️⭐️⭐️⭐️ Don't forget to leave a rating & review for Virtual Coffee! ⭐️⭐️⭐️⭐️⭐️ ----more---- Music: Blippy Trance by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/5759-blippy-trance License: http://creativecommons.org/licenses/by/4.0/

Rick Doblin, psychotherapist and the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), returns to chat about methylenedioxymethamphetamine (MDMA) and its positive effects on PTSD and trauma. Today, Doblin share what MDMA is, how it works, and how it can help those struggling with PTSD and trauma-related mental issues. We discuss how MDMA is used in therapy, the journey of it getting FDA approval, and the history of its development. We talk about: What is MDMA How does MDMA work How MDMA helps with PTSD and trauma Neuroplasticity Studies with MDMA How close is MDMA to FDA approval Exciting compounds of psychedelics and mental health

Rick Doblin, psychotherapist and the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), joins us to talk about how and why psychedelics are good for your mental health. Today, Doblin shares why he founded MAPS, his journey with psychedelics, and ending the war on drugs. We discuss psychedelic psychotherapy, the history and cultural impact of psychedelics, and how MAPS is helping with mental health. We talk about: Doblin's journey with psychedelics How are psychedelics good for your mental health Psychedelic psychotherapy Psychedelics in our culture The history of psychedelics What is MAPS

Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies, based in San Jose. He received his doctorate in Public Policy from Harvard's Kennedy School, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana. Doblin has devoted his life to the development of both of the drugs and a legal framework for the beneficial uses of psychedelics in the treatment of mental illnesses, including PTSD and long-term depression. Rick is also a licensed psychedelic therapist. Ismail Ali, who joins him in this week's podcast, directs legal and legislative policy for MAPS and is the former board chairman of the Students for Sensible Drug Policy.

For months, the world's leading science journals have been filled with the news of research trials on new drug treatments for disorders such as post-traumatic stress syndrome, clinical depression, and drug and alcohol addiction. What makes these treatments so remarkable is that they employ two powerful psychedelics, or hallucinogenic, compounds that provide patients with significant - and lasting - relief.The startling results have spring-boarded two once-taboo drugs – psilocybin and MDMA (aka "Ecstasy") – into mainstream medicine. Both psychedelics appear to be moving toward eventual FDA approval for clinical therapeutic use. Some states have already made them legal. Today on Midday: the potential, and perils, of psychedelic psychiatry. Two of the nation's leading researchers in this burgeoning field join Tom for the hour: Dr. Rick Doblinis the founder and executive director of the Multidisciplinary Association for Psychedelic Studies. MAPS is a Boston-based non-profit research, education and advocacy organization. Dr. Doblin leads more than a hundred neuroscientists, pharmacologists and regulatory specialists on a mission to bring psychedelic psychiatry into the medical mainstream. Dr. Doblin joins us on our digital line (and Zoom) from New York City… Dr. Roland Griffithsis a psycho-pharmacologist and professor of Psychiatry and Neurosciences at the Johns Hopkins University School of Medicine. He's also a specialist in mind-altering meditation practices, and the founding director of the two year-old Hopkins Center for Psychedelic and Consciousness Research. He is the author of a landmark 2006 study showing the beneficial effects of psilocybin. Dr. Griffiths join us on Zoom. Our guests also address listener questions and comments. See omnystudio.com/listener for privacy information.

In which John Heilemann talks with Rick Doblin, the pioneering champion of psychedelics who has waged a decades-long crusade to bring about mainstream acceptance of psychoactive drugs for therapeutic and recreational use. Heilemann and Doblin have known each other for more than 30 years, and they discuss Doblin's path-breaking work at the Multidisciplinary Association for Psychedelic Studies, which he founded and has turned into a multimillion dollar research and advocacy group employing 130 neuroscientists, pharmacologists, and regulatory specialists; his focus on paving the way for MDMA (aka Ecstasy or Molly) to be used in clinical settings as a treatment for depression, addiction, PTSD, and other maladies; how the cultural acceptance of marijuana (first as a medicine and then more broadly) is a leading indicator of where things are headed with MDMA, psilocybin mushrooms, LSD, and other mind-altering compounds; the future of psychedelic medicine, now that FDA approval is on the horizon; and the coming psychedelics investment bubble. Doblin also describes his personal experiences with psychedelics and how they changed his life, as well as the potential for backlash to the psychedelic renaissance, especially from fundamentalist groups, as social mores change.  Learn more about your ad-choices at https://www.iheartpodcastnetwork.com See acast.com/privacy for privacy and opt-out information.

In which John Heilemann talks with Rick Doblin, the pioneering champion of psychedelics who has waged a decades-long crusade to bring about mainstream acceptance of psychoactive drugs for therapeutic and recreational use. Heilemann and Doblin have known each other for more than 30 years, and they discuss Doblin’s path-breaking work at the Multidisciplinary Association for Psychedelic Studies, which he founded and has turned into a multimillion dollar research and advocacy group employing 130 neuroscientists, pharmacologists, and regulatory specialists; his focus on paving the way for MDMA (aka Ecstasy or Molly) to be used in clinical settings as a treatment for depression, addiction, PTSD, and other maladies; how the cultural acceptance of marijuana (first as a medicine and then more broadly) is a leading indicator of where things are headed with MDMA, psilocybin mushrooms, LSD, and other mind-altering compounds; the future of psychedelic medicine, now that FDA approval is on the horizon; and the coming psychedelics investment bubble. Doblin also describes his personal experiences with psychedelics and how they changed his life, as well as the potential for backlash to the psychedelic renaissance, especially from fundamentalist groups, as social mores change.  Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Richard ‘Rick' Doblin is the founder and director of Multidisciplinary Association for Psychedelic Studies (MAPS) - a non-profit research organisation established in 1986.  Somewhere between getting an undergraduate degree in psychology and a doctorate in public policy, Rick, having had discovered psychedelics, began his fight against unjustified criminalisation of psychedelic drugs.  Rick's main goal has been making MDMA a FDA-approved medicine, tune in to this week's episode to find out about his progress!MAPS latest MDMA study in Nature MedicineDrug Science live podcast recording with Professor David Nutt!  Multidisciplinary Association for Psychedelic Studies (MAPS)MDMACuban Missile Crisis, Vietnam War Carl JungLSDMescalineJohn Lilly Programming & Metaprogramming in the Human Biocomputer: Theory & ExperimentsRealms of the Human Unconscious: Observations from LSD Research by Stanislav GrofIsolation tankStanislav GrofPrimal therapyNew Genesis: Shaping a global spirituality by Robert MullerLaura HuxleyIsland by Aldous HuxleyDMTPsilocybinPost-traumatic stress disorder (PTSD)AyahuascaSpinal tapDissociative identity disorder ★ Support this podcast ★

Today Drew is joined by Dr. Rick Doblin, Executive Director Multidisciplinary Association for Psychedelic Studies (MAPS). Drew and Dr. Doblin discuss some exciting research being done right now regarding MDMA-assisted therapy and much more, learn more about Dr. Rick Doblin at maps.org. Visit AirMedCareNetwork.com/drew and use offer code DREW. Visit BetterHelp.com/DrDrew Visit ZocDoc.com/Drew Go to PublicRec.com Visit Headspace.com/drew Go to www.bioptimizers.com/drew and use coupon code DRDREW Visit AirDoctorPro.com and use the promo code DREW

I am quite excited about today's conversation as it is with a long-time good friend of mine, Dr. Bruce Doblin, who has been a lifelong general internal medicine practitioner. We explore the topic of Health & Care of oneself in this country; the challenges and opportunities for responsible health, changing the current paradigms and what it really takes to be a healthy WELL-Being for longevity. So, I ask you to stop and step out of the chaos of life again for an hour or so to learn, to grow, to hear another perspective, and to think about your own path of health, the stereotypes of health that are promoted and the small shifts you can make to become a better WELL-Being. Enjoy. Be Well, Marlo

Does a banned ‘party’ drug with a bad rep have the potential to change lives? Learn how psychedelics are changing not just how we treat mental illnesses, but how we think about mental health entirely.  Hear from psychedelic therapy’s most prominent advocate and MAPS.org founder and executive director, Rick Doblin. -- This program is produced by Mission.org and brought to you by Splunk, the Data-to-Everything Platform. Splunk helps organizations worldwide turn data into doing.  With solutions for IT, security, IoT and business operations, Splunk empowers people to make faster, better decisions and take action to get things done. Learn more at splunk.com. -- For full show notes and more, go to mission.org/hidden.

Lors de la capitulation de 1940, un fantassin français se donna la mort dans le village vosgien d’Housseras. Quatre ans après, il fut identifié comme ‘soldat Doblin, Vincent’. Mais sa véritable identité, sa vie et son histoire ne seront découvertes que bien plus tard : il s’agissait du mathématicien Wolfgang Döblin (né à Berlin en 1915), l’un des fils de l’écrivain et médecin allemand Alfred Döblin qui, d’origine juive et antinazi, avait dû fuir l'Allemagne avec sa famille en 1933. Ses derniers manuscrits (‘Sur l’équation de Kolmogoroff’), parvenus comme pli cacheté à l’Académie des sciences de Paris en février 1940, quatre mois avant sa mort à l’âge de 25 ans, ne pourront être étudiés qu’en 2000. Un documentaire de Jürgen Ellinghaus

Straight from the “innovation surgeon's general's" mouth you will experience a provocative clinic on what it takes to be an innovative company and become aware of the shallow practices that limit a given organization's quest to become a more disciplined innovator.

It was a tremendous honor speaking with Rick Doblin PhD about the pioneering work being done at MAPS, the Multi-Disciplinary Association of Psychedelic Studies, with MDMA-assisted psychotherapy, which stands as a likely cure for PTSD. We cover in-depth their novel approach to healthcare and prescription drugs. And MAPS' overarching goal of mass mental health and how this controversial therapy is poised to potentially disrupt/shift the broken medical models currently in place.   Show Notes Rick Doblin PhD Episode #10:   We discuss:   -MDMA-Assisted Therapeutic Protocol (5:30)   -MDMA helps people process painful emotions(6:30)   -People keep getting after two-month follow up (7:15)   -“When difficult emotions come up, and their standard approach before had been to suppress the emotions or to try to tranquilize with SSRI’s, to mute their emotions. That doesn’t have longterm benefits.” -Rick Doblin (7:35)   -Short term, a deep intervention that goes to the core of the problem.(7:52)    -MDMA-Assisted Therapy labeled FDA “Breakthrough Therapy” (8:17)     -Concept of Inner Healer (9:40)   -Eight-hour unscripted healing sessions (11:38)   -PTSD changes peoples brains: Fear processing part of the brain becomes hyperactive; Pre-Frontal Cortex, where we think logically is reduced activity; hippocampus, where we process memory into long-term storage is also reduced.(13:23)   -MDMA reduces activity in the amygdala, the fear processing part. (15:17)   -“PTSD changed my brain, and MDMA changed it back!” -Clinical Trials Patient(16:20)   -MDMA promotes new neural connections and releases oxytocin; strengthening prosocial parts of the brain. (16:50)   -MAPS: Non-profit Drug Development(21:45)   -“Not only are we trying to treat trauma, but we are trying to break the cycle of multi-generational trauma, that often has a conflict that goes back decades and centuries.” - Rick Doblin (24:05)   -MAPS.org/research Find treatment manual that describes the therapeutic approach. (24:40)   -Sept 2018: 1,036,000 US veterans receiving disability for PTSD.(25:14)   -Meditation, yoga, death/hospice, humane birthing, mindfulness all have been integrated into our culture (29:00)   -Tami Simon Insights at the Edge Podcast. (35:20)   -Abraham Maslow’s Hierarchy of Needs: Self-transcendence to reach Self-Actualization. (37:20)    -MAPS NFP Drug Company: “Not only are we trying to demonstrate a new approach to treating PTSD (with) Psychedelic-Assisted psychotherapy, but we are more broadly trying to demonstrate a new approach to provide healthcare and to provide prescription drugs in particular.” - Rick Doblin(40:30)   -MDMA was invented in 1912 and is off-patent - an anti-patent strategy developed. (42:00)   -MAPS For Profit Public Benefit Corporation. (44:20)   -Psychedelic State of the Union Address: The Future is Bright.(48:00)   -Psychedelic clinics on the horizon. (49:50)   -“Our goal is mass mental health! …Hopefully, a more spiritualized world with a lot less trauma.” -Rick Doblin(53:25)   -“Upside of global warming: People realizing—We are all in this together!”. - Rick Doblin(56:24)   To donate to MAPS or learn more about this pioneering work:   www.MAPS.org www.Clinicaltrials.gov   To support the Worth The Fight programming on Patreon: https://www.patreon.com/worththefightpodcast

Francisco Caffarena is the co-founder with Michael Harder of Sprout Stack. It’s an indoor farming business, that’s set to revolutionise the way fresh produce is grown and distributed in Sydney.In this episode, you’ll hear how Francisco and Michael are driven to overcome the challenges of weather disruption, climate change and food miles, that face traditional crop growers.Their combined skill sets, in agricultural science, electrical installation and construction, made an ideal partnership to launch their Ag-tech start-up, Sprout Stack.Together, they created an indoor farm in used shipping containers, filling them with vertical stacks of hydroponic trays. They transformed these containers to create a climate-controlled environment, in which their micro-crops can be watered, nurtured and regulated using integrated computer technology.As a result, Sprout Stack farms can be set-up and relocated in highly populated, urban areas like metro Sydney, so that fresh produce is grown locally and close to its end users.And in the Aftertaste section, I share the 10 different ways you could be more innovative in your business.You can learn more about Sprout Stack and connect with Francisco on:http://sproutstack.cohttps://www.instagram.com/sproutstack/https://www.facebook.com/sproutstack1/You can find more information about the 10 Types of Innovation by Doblin here:https://doblin.com/ten-typesMany thanks to this episode’s sponsor, the Food Innovation Centre at Monash.Find out how they can help your business become more innovative: https://www.foodinnovationcentre.com.auWant to learn more about how you could develop new products to drive growth in your food and beverage business? Try reading Susie’s Amazon Best-selling book, “Innovation Feast; Create new product ideas to feed your hungry business”. It’s available to purchase online at Amazon, Book Depository, Booktopia or via the website link below:https://eatdrinkinnovate.com.au/innovation-feast/

Listen NowPsychedelic agents or drugs, for example Lysergic Acid Diethylamide or LSD (a cereal fungus and first synthesized in 1938), were widely researched for their therapeutic potential through the 1950s.   Among other noted users of these agents was the actor, Cary Grant.  However, when these drugs escaped the research lab in the 1960s, moral panic set in.  America's youth would, it was feared, "turn on, tune in and drop out" (a phrase popularized the Berkeley/Harvard psychologist Timothy Leary) and social upheaval would ensue.  By 1970 LSD, psilocybin and other psychedelic agents were banned for both research and recreational use purposes.  Beginning in the 1990s the FDA began giving limited approval to conduct psychedelic-related efficacy studies.  Two decades later it appears the US has now, finally, turned the corner on researching the potential wide spread therapeutic benefits of psychedelics.  This was again made evident last month when by Johns Hopkins announced opening its Center for Psychedelic and Consciousness Research.  This announcement was preceded in April by the Imperial College in London announcing the opening of its Centre for Psychedelic Research.  During this 26 minute interview, Dr. Doblin begins by describing what effect these agents have on the brain or what parts of the brain are stimulated to what effect.  He discusses moreover his organization's MDMA (methylenedioxy-methamphetamine) research, currently a Phase 3 trial to study the effects on patients suffering from PTSD (oddly not supported by the DoD or VA), and a wide range of other current research efforts concerning treating, among other diagnoses, addiction, depression, eating disorders, phobias, OCD, schizophrenia and terminal illnesses.  He also weighs in on the future legal status of these drugs, again currently illegal or banned as Schedule I controlled substances. Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS).  He received his doctorate in Public Policy from Harvard's Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master's thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients.  His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences.  He also conducted a thirty-four year follow-up study to Timothy Leary's Concord Prison Experiment.  Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner.  His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist.  He founded MAPS in 1986.For information on MAPS go to: https://maps.org/.Information on Michael Pollen's 2018 work noted during this discussion, How to Change Your Mind,What the New Science of Psychedelics Teaches Us About Consciousness, Dying Addiction, Depression and Transcendence, go to: https://www.penguinrandomhouse.com/books/529343/how-to-change-your-mind-by-michael-pollan/.For a recent personal account of a psychedelic experience, see, for example, Helen Joyce, "My Adventures in Psychedelia," at: https://www.3quarksdaily.com/3quarksdaily/2019/10/my-adventures-in-psychedelia.html.   This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.thehealthcarepolicypodcast.com

Today's conversation is with my dear friend Jocelyn Ling, a tremendously talented Business Model Specialist in the Office of Innovation at Unicef. She's  currently on sabbatical from the Organizational Innovation consultancy Incandescent. She's been an interim biotech CEO, an investment consultant at the International Finance Corporation, the private investment arm of the World Bank Group, and even an instructor at Stanford's DSchool. The Show Notes section of this episode are pretty epic, since Jocelyn dropped a lot of knowledge and wisdom on me and you - frameworks aplenty for you to get a handle on designing the innovation conversation and leading the process, with, as she says, healthy skepticism, suspended judgment, and disciplined imagination.  I wanted to give that Hubble quote it's full space to breathe, because it's so lovely...I'm going to read it in full here: The scientist explores the world of phenomena by successive approximations. He knows that his data are not precise and that his theories must always be tested. It is quite natural that he tends to develop healthy skepticism, suspended judgment, and disciplined imagination.  — Edwin Powell Hubble There are a few subtle points that I want to tease out and draw your attention to as this all relates to conversation design and shaping them for the better. Invitation Jocelyn highlights one of my favorite ideas in conversation design - invitation. A leader invites participation through their own openness, not through force. Anyone can lead that openness to new ideas, even if they're not an “authorized” leader, through their own example. Invitations can look like asking the right questions or hosting teams or creating physical or mental space for the conversation. Cadence Jocelyn talks about the tempo of a team or an organization, and these larger conversions do have a tempo, just like a 1-on-1 conversation does. Leading the innovation conversation often means slowing down or speeding up that tempo to create clarity and safety or progress and speed. Goals Conversations start when people have a goal in mind. Each participant in the conversation will have their own idea of what that goal is and the innovation conversation is no different. Jocelyn points out, rightly, that it's critical for a team or an organization to develop their own clear, shared definition of innovation. I did a webinar recently with Mural and my partner in the Innovation Leadership Accelerator, Jay Melone, on just this topic, and you can find a link to the templates we used in the show notes...I think you'll find those helpful, too. Narrative Storytelling and coherent narratives are core components of everyday conversations and the innovation conversation is no different. What Jocelyn asks us to focus on is the idea of stories as memes - what happens to your story after you tell it? Does it communicate or convince? Great. Does that person retell that story and evangelize it for you? That's even better. Leading change means being able to tell the second type of story - viral anecdotes. That's all for now. The full transcript and show notes are right there in your podcasting app and on the website. Show Links and Notes Jocelyn Ling on the Internet http://jocelynling.com/ Making a Team Charter if you want a template (or just have the conversation!) https://blog.mural.co/team-charter https://www.unicef.org/innovation/ http://www.incandescent.com/ Michelle Gelfand's Rule Makers, Rule Breakers: How Tight and Loose Cultures Wire our World https://www.amazon.com/Rule-Makers-Breakers-Tight-Cultures/dp/1501152939 All in the Mind Podcast: https://www.abc.net.au/radionational/programs/allinthemind/the-power-of-social-norms/11178124 Clayton Christensen, Disruptive Innovation http://claytonchristensen.com/key-concepts/ Steven Johnson: Where Good Ideas Come From: The Natural History of Innovation https://www.amazon.com/Where-Good-Ideas-Come-Innovation/dp/1594485380 A blinkist version https://medium.com/key-lessons-from-books/the-key-lessons-from-where-good-ideas-come-from-by-steven-johnson-1798e11becdb Square Pegs and Round Holes in Apollo 13 https://www.youtube.com/watch?v=ry55--J4_VQ Google vs Apple in One Image, their patents map https://www.fastcompany.com/3068474/the-real-difference-between-google-and-apple Edwin Hubble Quote: The scientist explores the world of phenomena by successive approximations. He knows that his data are not precise and that his theories must always be tested. It is quite natural that he tends to develop healthy skepticism, suspended judgment, and disciplined imagination.  — Edwin Powell Hubble In Commencement Address, California Institute of Technology 10 Jun 1938 More on Hubble:  https://www.spacetelescope.org/about/history/the_man_behind_the_name/ The Innovation/Ambition Matrix Core, Adjacent, Transformational   How to have the Innovation Conversation: https://blog.mural.co/innovation-leadership The 21st Century Ger Project: https://www.forbes.com/sites/unicefusa/2018/07/05/redesigning-the-mongolian-ger-to-help-solve-a-health-crisis/ Doblin's Ten Types of Innovation: https://doblin.com/dist/images/uploads/Doblin_TenTypesBrochure_Web.pdf Six Sigma and the Eight Types of Waste https://goleansixsigma.com/8-wastes/ The Forgetting Curve (Distributed Practice!) https://en.wikipedia.org/wiki/Forgetting_curve Behavioral Design with Matt Mayberry from Boundless Mind http://theconversationfactory.com/podcast/2018/6/6/behavioral-design-in-the-real-world-with-matt-mayberry Transcription: Daniel:  I'm going to officially welcome you to the conversation factory. So we're going to start the real, quote unquote real conversation now. Um, because I feel like every conversation we have is like, is interesting and insightful for me and it's never on the record. Jocelyn:  Lets make this on the record! Daniel:   We're going to make this on the record! And if you ever want me to, if you want me to take any pieces off the record, you just let me know. I think the reason why I wanted to have this conversation with you about innovation leadership is, I'm going to go way back. One of my earliest memories of you is back when we were co-designing early, like an early iteration of what the design gym was going to be. we were sitting down with, you Me... Maybe it was Andy, it was probably Andy and you were like, let's have a conversation about our working styles. Jocelyn:   Oh Wow. I don't ever remember that. Yeah, that does sound like something that I do and I did. I still do it till today, with any new team Daniel:  Yeah. Well, so like that was my first time somebody had invited me into that conversation and it blew me away because I'd never really, I mean this is going back. I mean this is 2012 I guess this is a long time ago. I had never really thought about how I work. Nobody had asked me that question. I'd never had that conversation about how and where do I like the, what I would now call the interfaces of my work conversations to happen. And I'm just wondering like, who introduced you into that conversation and where did you learn some of these soft skills? I mean, this is a quote unquote soft skill. Where did you learn some of the soft skills that you do in your work that you use in your work? Jocelyn:   That's a great question. I think that probably learned a lot of my soft skills through day to day interaction. I think I've had the privilege, like in my job, given that I was an investor before, as well as in consulting to have exposure to a very broad range of working styles and leaders. And particularly so in the consulting world, you are especially attuned to how clients work. And so I always try and make sure that I am not only understanding how teams come together, but also how individuals work because as a consultant it's up to me to match and really tap into what is an invitation into their world. So I think that's how I survived, absorbed it over time. I think specifically maybe at that point in time and I continued to refine how I work with teams over the years, but maybe back in 2012 likely from, um, a really wonderful mentor in Boston, mine who I worked at International finance corporation at the World Bank. Um, my boss at that time, BG Mohandas is and continues to be an amazing person in my life. Uh, probably taught me that specific question and style. Daniel:  That's amazing. And like, do you ever feel like, um, that that's an unwelcome conversation or is it ever hard to bring that topic up for you? Jocelyn:   I often find it's as easy and very welcomed conversation and that is an investment of even 20 minutes with a new team member goes a very long way to setting the tone for their relationship and for the partnership. Daniel:   Yeah. Yeah. It's interesting this idea of, of a pattern matching like perceiving patterns in somebody else's behavior and then making that effort to sort of like alter your own. Jocelyn:  Oh, absolutely. I think that, um, and this is something I learned in my incandescent work. It's like the concept tempo. And I think you and I might have even spoken about it before, that not only understanding the tempo of an organization and by tempo I mean like the speed of how a team comes together and moves and how an individual does work. So you can imagine and overly generalize and say a startup has a really fast tempo comparatively to a larger fortune 500 company, which runs a little bit slower. And it's in the more that you're able to understand what Beat and Tempo you're stepping into, I think the more than you can learn to be effective in the kind of work that you want to achieve. Daniel:  Yeah. Well so perceiving that tempo and then the ability to do something about it. I was literally, I'm bringing it up right now, so I'm just listening to a podcast, um, called all in the mind and they're interviewing. Who are they interviewing? Why is it so hard to find the show notes on these things? This is ridiculous. I can't believe I'm doing this on the phone. Um, Michelle Gelfand, she, she wrote a book, um, about um, making and breaking cultural rules and she has this idea of tight and loose cultures like cultures where social norms are tight and people follow all the norms and loose cultures where people don't. So I love the idea that you're also noticing, you know, there's, there's probably tight and loose work cultures but fast and slow ones. Right Jocelyn:   Absolutely. Daniel: I'm wondering, this seems like a good time. I feel like I have a tendency to like plop people in the middle of a conversation. Um, if you want to backtrack and tell the folks in radio land a little bit about your career journey, like what you're doing now and what brought you into what you're, what you're doing now. Jocelyn:  Yeah, sure. So my background, it's sort of like a combination of different things. Um, I like to think that, um, any exploration that I take always leads me to another interesting opening. Um, I started out my career in finance, um, with the Royal Bank of Canada and then followed a slightly untraditional path in that I then moved, um, from where I was living at a time from Vancouver and I moved to New York to then, uh, be in full exploration and ambiguity mode. And that's when you and I met Daniel to start this, start the Design Gym, which was something completely new, entrepreneurial in a new field. And that's also where I got introduced to the world design and absolutely fell in love with it. We started an accidental company together. Daniel:   Yup. Jocelyn:  And then along the way ran into visa issues. And got kicked out of the United States, if you remember that, too! Daniel:  I do! Jocelyn:   And then found myself in Kenya where I then work in impact investing with an amazing nonprofit and then later on the World Bank and then found my way back to New York. The US couldn't get rid of me that quickly! Came back to the US legally with a visa in hand and, uh, worked for a strategy consulting organization, design firm called incandescent. And I've been there for the past, uh, five plus years now and, and right now I'm on sabbatical with the firm and have taken up residency at a UNICEF innovation team. So it's been a meandering path, but all for wonderful teams and causes. Daniel:  So not everyone will know this, but like, I feel like, um, you are amazingly one of the many people try to get in touch with you through me on Linkedin. Um, when they're, when they're interested in organizational design and organizational innovation...incandescent, like is, uh, is a decent player in that space. Um, I don't know how they, how they managed to build their name. Maybe it's...I'm assuming they do good wor Jocelyn:  Oh, I hope so! Daniel:  I don't know none of it from firsthand, but like five years. Can you tell me a little bit about what, what organizational innovation and uh, and some of the tempo work that you're doing with that you did that incandescent? I'm asking you to sum up five years of work! Jocelyn:  I'm going to reframe your question slightly because I think that what might be more interesting instead of me naming off projects for folks is to share some first principles of how we work, which could be interesting cause we bring that into every single client engagement that we do. So Indandecent was founded by a man called Niko Canner, a wonderfully brilliant individual, also a mentor in my life. Um, and I've learned so much from him and joined the firm when it was just him and another individual. So I was his second hire. Um, and it was found with the focus of how do we understand, how do, how do we build beautiful businesses? Um, and how might we build this in an intentional way that you're really looking and thinking about the whole system from the start? So that's one of the principles of how we look at things. Jocelyn:  It's like how do, how does a organization as a system work together? I think oftentimes when consultants like step into a project, their worldview is a very specific task or project that has been carved out for them. When Incandescent steps into a project. We always ask the question, how does this touch our other things and how do we ensure that all of the nodes that it touches works together? So they were designing something that sustains and lasts and not just some designing something for in the moment.So that's one, one of the mindsets and principles are how we bring, um, things in l Daniel:   Long term thinking! Jocelyn:   yeah, absolutely. Long term thinking. The second one would be, um, we literally do our work in principles. We will spend a lot of time upfront, um, whether we're designing, uh, how a team comes together, whether we're designing a strategy. A lot of it, a lot of our time that's invested upfront is in what are the principles of how a team would work together, what are the principles of strategy? Um, and once you clarify that, it just unlocks so many things. It has a waterfall effect, um, in terms of just like designing everything else from that. So I think that's another way of how we work. And I think the third is probably a high amount of, um, intentionality and co-creation. So we always designed something with the client. Um, and I think that part of that then hopefully leads to really great work because we're not designing in a vacuum. Daniel:   Yeah. So a lot of it goes to like, this is, uh, I've, I've just recently been reintroduced to the term prejecting. There's the project and then there's the preject. But it seems like the prejecting phase where you really think about the whole system and the team principles and Co creation, a lot of that just sort of falls, falls into place from that, right? Jocelyn:  Yep, absolutely. And let me give an example of that, just to bring it to life. So about two and a half years ago, we were approached by three major foundations like the gates foundation, the Hewlett Foundation and Ciaran investment foundation and they came to us were referral and they said, we're interested in designing, we're interested in putting together a conference in the world of adolescent sexual and reproductive health and to bring together designers and global health folks and put them a conference together and on the call with them we set food. That's really interesting, but we're not really just conference folks and event planners. There are many people who do that, but if you're interested in what the representation of what this conference is, which is if you see this as a watershed moment for how design can be brought into the world of adolescent sexual reproductive health, let's talk about that Jocelyn:   Let's talk about like what this conference is enabling a strategy which hopefully the three foundations would might have or is interested in doing and the three program officers were really interested in having a conversation. They had an Aha moment on the call and said, we want that. You want to think about a larger strategy and how us as funders can come together. And um, that kick started two years worth of work where we did end up designing a convening and a conference. But we also ended up really bringing to life a strategy that, um, was unique to the field. And that was very much co-created with these three program officers through lots of working sessions remotely and we were all in different locations over time. So hopefully that example brings to life some of the things I think I've spoken on before. Daniel:  It does. And it also like is a wonderful case study of reframing and engaging stakeholders in conversation. Like not starting from a no, but starting from a, Oh, isn't that interesting? Or Oh well why is that important to you? Jocelyn:  Yeah, it's like my favorite Albert Einstein quote, it's like if I had 60 minutes to save the world, I'll spend 55 minutes defining the problem and five minutes coming up with a solution. So like if you're solving for the wrong problem or if you don't even realize what you actually really want. I think there's a lot of room to think through that together. Daniel:   Yeah. Well, so I mean this goes to this, this question of like what innovation even means, what problem solving means and it seems like it's really attached to systems thinking for you and at least in your working in Indandecent like defining what the boundary of the problem is is really, really essential. In that sense it almost makes a like a linear or simple definition of innovation really hard I would think. Jocelyn:   I mean innovation is such a complex topic of which there are many, many definitions. Like you can range anything from Clay Christensen's disruptive innovation definition to um, I don't know, Steven Johnson's book, which I really like... Where good ideas come from. He defines innovation in a different way. And all that really matters is that the organization that you work for and the team that you are on has one single definition of which all of you agree on. And that's clear. Daniel:   We'll wait, hold a second. Jocelyn:   There are so many! Daniel:  Well, let's, let's roll. Let's roll it back. Cause like I'm, my, my brain is remembering Steven Johnson's book... It's like, yeah, I think of it as like, um, that moment in a, I think it's Apollo 13 when they like dump out all these, the bucket of parts that they're like, this is what the astronauts have on board and we need to literally make a square peg connect to a round hole. Like let's figure it out. And it always felt to me like Steven Johnson's definition was the more parts you have, the more pieces you can put together. Um, it's like, it's, it's having a wide ranging mind and absorbing lots of influences. Jocelyn:   Yeah. I mean, Steven Johnson, I think he talks about, I don't know whether he likes specifically names a concise one sentence definition, but I think he talks about the fact that innovation happens within the bounds of the adjacent possible. In other words, like the realm of possibilities available at any given moment. Daniel:   Yeah. Right. And that we build on those adjacent possibles. So I guess maybe where I would, I'm backing myself into agreeing with you cause like I was like, Oh, do we all have to have the same definition of innovation? Um, we, we do, in order to try something we have to say like, Oh, here's all these things we could try. I think this would be more, uh, impactful. Right. And that that's a conversation that, that somebody needs to be able to dare I say, facilitate in order for the innovation conversation to proceed. Jocelyn:   Yup. Agree. Daniel:   Okay. Glad you agree with me! Well, so then like what, um, what, how, how can I be more provocative and get you to disagree with me? What, like what, what do you, what have you seen in terms of like a leader's ability to, uh, foster, uh, or, or, or what's the opposite of foster disable innovation inside of a team, inside of an organization, in your own experience? Jocelyn:  Um, I mean, I think the role of a leader, I have a feeling you're going to agree with me, but I think the role of a leader is very simply to create the conditions that, that foster and support innovation. What I mean by that is openness. Um, and to extend invitations out to their teams, whether that's actually literally or even in a physical space or to, uh, lead by example. I think once you create the leading by example and the creation of conditions, there could be many other elements to that. But those two are to me, feels core to what a role of a leader should do. Daniel:  Yeah. Well, so then this goes to the, the idea that a leader doesn't necessarily have to be authorized. Jocelyn:  No, not necessarily. Yeah. On that note, I actually think that it really depends on the organization and, and how far the authorization can take you. So for example, if I compare contrast and apple versus Google, um, and does a really wonderful graphic of the number of patents that each organization has filed over the years. And in Google's, it looks like it's all over. You can see sort of like patterns that emerge like literally visually from all over the organization and from our authorization standpoint. Like folks are welcomed and encouraged to explore ideas and invent new things. And you see that through patents that had been filed across the organization versus apples, it's a lot more concentrated because it's a lot more centralized and they have much more of a stage gated process. I would imagine. I'm not to say that one is correct or wrong, it just, again, it depends on the kind of organization and how clear you are. Um, overall on how innovation is being fostered.. Daniel:  Yeah. Well, I mean, how, how, how does a leader maintain that clarity I guess? Is, is, uh, it's an interesting question. Jocelyn:   That's a great question. Um, maybe they can think about in clarity in terms of creating a discipline and a ritual where, I know it sounds counter intuitive, but I think a lot of, when a lot of times people think about innovation, people think about it as serendipitous moments that come to you. I actually think that innovation comes to you in a much more disciplined way when you actually continuously put sustained effort, um, into exploring x, whatever that x might be. Um, again, very close. I'm gonna bring up Steven Johnson again. But like I think that his ideas around the exploration of the adjacent possible, unless there's sustained probing, you're not going to suddenly one day come up with a huge Aha if you've never thought about that topic. You know, for example, like I have never thought about a topic of um, the reinvention of, of uh, space rocket, Daniel:  I love that you're struggling to think of something you've never thought of! Jocelyn: Right! Like...How to I reinvent a space rocker, I don't know! I've spent hardly any time thinking about that. And so it's highly unlikely that I am sitting here with suddenly come up with something breakthrough right in that area. Daniel:  Whereas there's people who are literally pounding their heads on that boundary constantly. And of course those are the people who are going to be like, what if we...? Jocelyn:   Yeah, absolutely. And so as a leader, if you create the space of, Hey, every week we'll have a ritual and this is just a very specific tactical example of I'm going to solicit ideas from the team around the boundaries of building a new space rocket. Then maybe it will have interesting ideas. They eventually come up over time. Daniel:   So there's like my, there's a couple of things I want to probe on. Like one is we were talking about cadence and tempo of organizations and then you use the term ritual. Uh, and I feel like those two are really intimately related to, I'm literally working, the podcast interview I'm working on right now is all about ritual, uh, and designing rituals for people in it. And it's sort of an interesting thing to think about what the cadence of these, um, innovation rituals, uh, could be like. And, and what are you find are some, I don't know, do are, are there some that you're like, oh, here are the basics. Here are the essentials of innovation rituals. We talked about one, which was like the team. Jocelyn:   Yeah. Daniel:  Team alignment conversation. It's like a really powerful ritual for at least making sure that we're all working in this in, in ways that are harmonious, which is really, really valuable. Jocelyn:   ...great question. Well, one ritual that I really like is something that I know, uh, the design gym that we do. And also folks that I you does as well is that they have inspiration trips. Um, that teams would go and say, hey, we're starting something new and here's a new topic that none of us have really thought about before. How, how might we go and get inspired? And if you have that as a ritual when you start, whether it's a new project or even midway when you're stuck, I think that could be a really powerful thing to get unstuck. Um, instead of churning internally. And I really liked that concept. Um, overall to just look externally, whether it's true, take a moment and actually physically be in another location or to learn by having conversations with others that are different. Daniel:   Yeah. Yeah. I think the, and behind that is this idea of being able to identify what the real need is. I think about it in two ways. One is like, let me go see where else this problem is being solved. Like specifically like, and then there's like, let me see in a broader sense like what other types of problems are similar to this? And, and this could be like, oh, let me, like if, if any other countries willing to share with me how they're doing rocket flight, then maybe I can learn the totality of the problem. But you can also do the thing where like, hey, let's look at what bees do and let's look at what seagulls do and let's look at other types of propulsion. Um, and so I feel like that's like that that definitely goes to the like the breadth of, of inspiration... Jocelyn:   absolutely. Daniel:  Well I think, and I guess that's where like, you know, cause what I was excited to talk with you about is like good leadership and bad leadership skills. And it seems like a really, really powerful leadership skill is the willingness and the interest, the curiosity, but also the willingness to sort of like look at the boundary of the possible and say what else is possible. Jocelyn:  Yep. Absolutely. I also think that a great leadership skill in when leading an innovation team is, um, knowing what bets to place at any given period of time. So one of my favorite quotes is by Edwin Hubble. Um, and he says, and he said this in like a 1930s in his cal tech commencement speech being says that a scientist has a healthy skepticism, suspended judgment and disciplined imagination. I'm going to say those three things again because I love the combination of the three assigned. His has a healthy skepticism, suspended judgment and discipline imagination. And he talks about it specifically in the world science, but I think it's actually really applicable in the world of innovation because he describes a way of being, which is kind of strange. You're supposed to be skeptical, but you're also suppose to suspend your judgment. You're supposed to have the imagination, but this upland because you don't want me to go too wild. And I think that, um, the balance between the three of how do you actually observe ideas that come in, gathering facts, understanding it, testing your expectations against them, um, is I think a quality that I would hope anyone who's leading innovation would have. Daniel:   Hm. That's really beautiful. I, and when did you absorb that quote that's like, it's seems really close to your heart, which is beautiful. Jocelyn:   Um, great question. I learned here when I was interim CEO of a biotech company in incandescence portfolio, I'd taken over and I was new to the world of science, also new to being an CEO of a startup. And one of the biggest lessons I took away was that quote is I think that there is such a beautiful orientation in terms of how scientists discover things. Um, it's really their way of being. Um, and my brother actually is a scientist and I see how he thinks about problems and how he approaches them. It just, that combination of when is it the right moment to imagine something really amazing. Because a lot of scientists, they don't know what they're discovering. They're just out there. Yeah. Um, oh, when is it? The moment when you were gathering back a set of data and you're saying, hmm, does data's actually telling me that it's not that great and that is not the direction that I should go in? And just being, and really refining the balance between the three modes whenever you're faced with facts or contradictory pieces of evidence, I think is, um, something that I will always be very grateful for for my time. And as a biotech CEO, Daniel:   something I can't say at all, I've never done that, Jocelyn:   hey, one of my other lives, you know. Daniel:  Well, so this actually goes back to, um, like an organization has got to have multiple bets, right? And they need to have, uh, uh, a roadmap of, you know, crazy bets and less crazy bets. And in a sense like I would, I would integrate that as an innovation leadership skill. 100% is the ability to like, uh, you know, what would you call it? Handicap, um, various items on the roadmap, but then also like to, to, to, to make sure that those bets are spread out. Jocelyn:  Yup. Have you heard of the ambition matrix before or seen the framework of it? The ambition matrix? Daniel:   No. Illuminate me! Jocelyn:   so it's a pretty simple framework. Um, where I think on one of the axes is solutions. The other axis is challenge, but in any case it's basically concentric circles like moving out of core, adjacent and transformational... and where it talks about how do you actually categorize your bets in terms of innovations or core innovation is something that's very different but also very needed comparatively to something transformational. Um, and I think visualizing it that way could be really helpful when facilitating a conversation. Daniel:  Have, have you utilized that in your, in your own work? Jocelyn:  Uh, we are actually looking at the application of it at UNICEF right now where we're looking at how we're, how different projects could be core, adjacent and transformational. Daniel:   Uh, can you, can you say a little bit more about that and maybe tell us a little bit about, uh, the, the role you're, you're doing right now? because I don't know too much about it yet. Jocelyn:   Sure. I mean, and now we're getting sort of like a little bit into the new ones of like how has variation different in the world of international development versus in the world of the private sector? Um, there, there are different lenses that one might me take. Um, at UNICEF and my role is as a business model specialist on the scale team, the current innovation team is divided into three pillars. We have a futures arm where we look at what are new landscapes and markets are sort of shaping out there. We have a ventures arm which looks at um, deploying capital in frontier technologies. So think block chain, drones, all fall under the ventures arm. And then we have a scale team and that's where I sit. Um, and the way that we think about innovation is like how might we accelerate projects or programs that are demonstrating a lot of practice but need to go to scale and actually spread a lot faster than your current rate of expansion. So those are three different lenses. The very definition obviously of innovation varies depending on the lens that you take. Because like a venture's lens for example, is they're using capital...an now we're getting a little bit more into the strategy side, but were they using capital as an accelerant versus ... we are using actual internal capabilities on the scale team to uh, accelerate innovation. Daniel:  Huh. That, that's interesting. Well, so like can capital accelerate the innovation itself or can capital accelerate the spread of the putative innovation or learning about whether or not it is in fact effective at scale? Jocelyn:   Probably both. I think that UNICEF takes the fans that we are a catalyst in an ecosystem and if somebody else is doing something that's really wonderful, like what is the best role that we might be able to play? And in that case it could be the provision of capital. Um, in some other areas like in scale, it might be the deployment of internal capabilities and in the futures team it could be putting out a thought leadership piece on how urban innovation works or, um, one of our other projects is, you know, just to give you an example is, um, what we're calling a 21st century Ger project where we have brought together different partners in the private sector and academia. Um, Arc'Teryx, North Face, University of Pennsylvania to help us redesign a Mongolian Ger, uh, which is those Yurts that, uh, folks live in. It's a materials design project in order to increase an improved installation of these structures that folks live in, which would help with air pollution. Because right now these yurts are not insulated very well and families end up burning a lot of coal internally, which causes a lot of health issues. Um, but if we're able to actually improve the installation, then we're able to, uh, help from a health perspective for all of these different families. But that's a futures project... no one else is doing that in the market, it's pretty niche but much needed in terms of urban innovation. And we have a really fantastic set of partners that are working with us on it. Daniel:  That's so cool. And, and what that really illustrates for me is like how many levers there are for a change. Like, cause obviously you could also be working on the combustion side, right? Or on the electrical generation side. Jocelyn:   Absolutely. Daniel:   And, and doing and it sounds like there's been a decision and it makes a lot of sense actually. Cause this I've known about this problem, it's like I never once thought about it from the installation side, which is really subtle. Jocelyn:   yeah. Um, there's a really wonderful framework. I feel like I'm throwing a lot of frameworks, Daniel:   I love frameworks! Jocelyn:   I figured it's you, so I'll just throw out all the frameworks in the world because they know you love them. Um, if you haven't seen Doblin 10 types of innovation, sure. I would highly recommend that you take a look at that because he talks about, uh, it breaks it down into basically three large categories, configuration which is made out of your profit model and network structure process you're offering. So product performance, product system and you experience, so like your service, your cattle, your brand, your customer engagement, you can innovate along any of these things, um, and have it be a really wonderful type of innovation. Or you could even combine different categories together to actually have something more transformational. So for example, a core... Just use the ambition matrix against this new types of innovation. Jocelyn:   A core innovation for um, a, let's see, a channel or brand could be a new campaign that they have never thought about before. And it's fundamentally, you know, people, or a brand might choose to use Instagram, which is a channel they may not have ever used before in terms of reaching a completely new segment of audience. Or they could combine different things together, like a profit model combined with product performance combined with customer engagement, which are three different things, which is the example of the Mongolian Ger project that I just gave you, which is how do we actually improve not only on the product or on the distribution on it and involve the Mongolian government to help with the profit model side and then also engage users as part of the understanding from a health care standpoint that burning so much coal, um, would affect your health x ways. Daniel:   So this really goes back to the, the idea that this can be a discipline and Yup. And, and, and my mind is going back to, like, six sigma. Like here are the types of wastes and yeah, you could also think like, okay, well how can we improve this system? And what you're doing is you're reducing the loss of heat, right. As opposed to focusing on the efficiency of the generation of the heat. That's just really cool. Um, but at the same time, I feel like sometimes these, the, the discipline is not a replacement for somebody seeing potential. Like, so this goes back to like your skill as a business designer, which is like how did you do this? How does one decide if something's got a putative legs? You know, you're like, oh, this has got, this is there's some juice here that's worth the squeeze. Jocelyn:   Yeah, yeah, absolutely. I think that, um, on that particular project, I, I really have to credit the team behind that where it was not only the partnerships team that, so a lot of potential, but it was the futures team and also the head of the scale team that said, oh, there is something really interesting here. I think that this reframing of how we relate to heat could result in something really breakthrough. And we have a really fantastic partner arc'teryx who said, great, let's try it out. What's the worst thing, you know, in the spirit of design thinking, let's try out a prototype and see what happens. Daniel:   Yeah. Well, so then, yeah, this, this is, we're like building out a, a lovely model of innovation leadership here. Why don't we just like a fearlessness, a willingness to prototype, but I think there's also another piece which, which we're like getting towards which is like storytelling, which is like the ability to communicate to somebody an opportunity that you perceive that maybe they don't perceive. Jocelyn: Yep. How do you think that, given that you work so much in the conversation side of things, how do you think that storytelling or facilitation changes with this innovation leadership lens? Does it change or does it not change from a skillset standpoint? Daniel:   I mean, I think storytelling...you just reverse interviewed me, Jocelyn! I mean I believe that a storytelling is like really fundamental. Like I, my, my love for storytelling and narrative is like one of the reasons why I made a narrative phase in the design gym model. There isn't a narrative phase in ideas model, which I think is actually a major failing. It sort of stands outside of the design thinking process. Whereas I think that it is, it is design thinking is a way of telling stories. Um, I have to think in when we talk, each phrase that we respond to each other with is forming a story and like, what's like, if I say a non-sequitur, it's like we define a non-sequitur as something that's not linked to the rest of the conversation, it doesn't, it doesn't connect or it doesn't relate. So I think, um, great story telling makes things seem obvious, right? Like it, which is sort of like, hey, here's this amazing opportunity and here's this huge problem and we should do something about it right now. Like that's just the fundamental innovation storytelling model, right? That I know, like, I dunno what, what, what's your, what your core story telling you know, framework is like, when you want to make sure that you're communicating that value to someone else. Like what, what you, how do you make sure that rises up from all of the, the, the charts and figures. Jocelyn:  Yeah. I don't know if I have a storytelling of framework per se, but what I do think storytelling needs to be, are powerful anecdotes that somebody else can tell the story on behalf of you. So you maybe it needs to be memorable enough. Yes. And one of the stories that comes to mind, um, and this is not a client that I've worked with and is more of an anecdote that a colleague of mine has told me is that, um, when he was visiting the headquarters of Alcoa, which is a mining company, um, and he was running late for a meeting and he was in their London offices and arrived like just on time. They made him sit through a 10 minute training video on safety, even though they were in the middle of London. There were no mines around anywhere. Jocelyn:   They were in professional building. But you have to sit through 10 minutes of training because that was one of their core values, um, that it, that they really wanted to talk about in Alcoa. And the reason for that is when the new, and this is, um, this is definitely a couple years ago when a new CEO of Alcoa came in to take over the company. At the point in time, he decided that the way that he was going to turn around the company was through a message of safety. And so every single call that he did with his earnings, with his leadership team, um, with employees that he would meet, he would ask them, how are you actually talking or implementing safety in your teams? Um, and it's one of the safest places to work right now. Um, which is kind of insane. Well, for a mining company and even more so than than, um, other mining companies that are out there. But then he just really drove that message home by building it into one of the core values of the organization. And that culture is spread through asking that simple question and that people could retell and say, here's how a CEO and a thinks about it. Yeah. It's not really sort of like on the innovation lines, but I think it goes to your storytelling point around how the things get told, um, and emphasized upon. Daniel:   Yeah, it's that drumbeat. Uh, and whatever you are talking about is what will be on top of people's mind and it's what will happen. It's really cool. What a great story. I'll retell that. I don't think people often think about storytelling, uh, in terms of what will happen after I tell the story. Um, yeah, and designing for retelling is definitely a really important heuristic for, for, you know, if you're going to architect the narrative for sure. simplify. Um, so Jocelyn, we're coming up against our, our, um, our time together this time together. Is there anything else that, um, that we haven't talked about that you think is worth bringing, bringing up, uh, on these topics? Any thread that we've left loose that, that's, that's, uh, sticking out of your mind? Jocelyn:  Um, the only other thing that comes to mind is the topic on learning, which I feel like could take a whole other session on its own. Um, but I wonder whether there's anything that you would like to unpack around there because I think so much of creating a discipline in ritual for yourself is also paired from a complimentary standpoint of how does one learn and how does one practice? Because that's it goes hand in hand. You can't really create a discipline without actually practicing something. Yeah. Um, Daniel:  well you talked a little bit about this in terms of like, uh, uh, the organizational capability is part of the innovation, but then inside of that capability are people and people, uh, change at the rate of, uh, people, human conversation developmentally happens. Yeah. I don't know, at a certain pace, um, in which case like, how can you, you know, increase that for an organization? How can you increase that for, for a person. But I think it seems like you're, you're positing and I agree with you that like, um, having some, some discipline around it, having some frameworks about can, can really help people. Jocelyn:  Yup. Daniel:   Couldn't agree more. We just tied a bow around that. Yep. How do you feel like you've grown in your own capabilities? Like I feel like you've, you've gone from strength to strength, your increase in your career. How do you stay focused on, on your own growth? Jocelyn:   great question. I think, um, from a practice standpoint, I think something that I do, and I don't know how intentionally I truly do this, but definitely it's woven into, uh, my day to day is that I practice, I do a lot of distributed practice. I don't know if that's an that's an actual term. I don't know, maybe I just coined that. Daniel:   Well, it is now! Jocelyn:  And what I mean by that is, um, I try and make sure, like whenever I learn a new concept or a new skill set that I, I, uh, practice it sporadically and in a very spread out way. So for example, I'm not in the world of design thinking right now and neither am I a designer. There was a period of my life where I was very immersed in it and that was all I was reading and thinking and speaking about on a day to day basis. Now I have a different lens and focus, but I still upkeep my design thinking side, um, to whether that's like sporadic engagements or, um, and I teach stuff like at the d school and that's pretty nice, like longer term cadence to force me to actually think about like new concepts in design or I go to design events or read books and there isn't....it's no way near the intensity's uh, we read it, my intensity a hundred back then. Jocelyn: It's like now it's probably about 15 to 20% of my time and attention, but I kind of keep that on the back burner so that I don't actually lose touch of that. Um, and to also make sure that I remember a lot of the things that I've learned because I think it's easy to pick up something and just let it go and never touch it.. And what's learning something if you don't actually retain things that you're interested in? Daniel: Yeah. This is like, you are using the forgetting curve to your advantage. This is the forgetting curve. I'll, I'll send you a link. I'll put the link in the show notes. I, well, I interviewed somebody, a behavioral, a guy who works for a behavioral Science Company called Boundless Mind and behavioral change works with the, like if I tell you a number today like your, it has no emotional impact but you may remember it in two or two or three or five or 10 minutes, um, the odds of you remembering it next week and very slim. But if I call you up tomorrow and say, Hey Jocelyn, I'm going to call you tomorrow and I'm going to ask you what the number is, you might remember it. And then if like I call you up in, in like another week and I'm like, Hey, you remember what that number is? You're like, oh yeah, I remember the number. Or at least like what the range is like. So it's about like, just like, like, like the radioactive decay curve. Jocelyn: Um, oh, got it. Okay....that's the name of the concept. Not really distributed practice,Daniel: but I like distributed, I think distributed practice is much better. But yeah, that's like, that's the idea is like you're making sure that you are being intentional about keeping it... As my father would say, a used key is always bright. Jocelyn: There you go. Yes. I love that. Daniel: Um, the, the fact that I got into a quote from my father means that it's time for us to stop. Jocelyn: Um, thank you so much for having me. Really Fun as always. Daniel: Yeah, it is. We enjoy our conversations. Likewise. I really appreciate you making the time.  

Trevahr interviews Rick Doblin about MAPS and the progressive task of bringing psychedelic medicine to the approving eyes of the public and lawmakers in the USA. He talks about current projects in 2010. At this time Trevahr Ryan Hughes and Xana Moonflower were conducting shows together weekly, and this was recorded live on July 2010. Rick Doblin, PhD, is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS; maps.org). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master's thesis on a survey of oncologists about medical marijuana for cancer patients. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife and three children.

For three decades, Rick Doblin, PhD, has been working in human connection. Doblin is the founder and executive director of the legendary Multidisciplinary Association for Psychedelic Studies (MAPS). And he’s known for pushing forward critical research to explore the therapeutic potential of psychedelic experiences. But that’s only a piece of it. In this conversation with Elise, Doblin shares his profound perspective on our potential to heal ourselves and on the different pathways that we can open up to process traumas and wrongs done to us—and by us. He explains the significance of changing our relationship to our memories, getting in touch with our unconscious, and learning to forgive ourselves when it’s hardest. (For more, check out The goop Podcast hub.)

Okay, so that joke's up. I've grilled students on their internships all year long, I figure maybe it's time to talk about my own experience! On this episode, I talk about my experience at Doblin, a company that combines the world of design and innovation with business. (ft. Special Guest Interviewer....). Enjoy!Copyright Akash Pasricha 2019. All rights reserved.

Okay, so that joke's up. I've grilled students on their internships all year long, I figure maybe it's time to talk about my own experience! On this episode, I talk about my experience at Doblin, a company that combines the world of design and innovation with business. (ft. Special Guest Interviewer....). Enjoy!Copyright Akash Pasricha 2019. All rights reserved.

Welcome to another episode of the Bowie Book Club, where wild speculation and grasping for straws about Bowie’s favorite books has reigned supreme since 2016. This time we read Berlin Alexanderplatz, a classic of German modernism by Alfred Doblin, and another trip to Berlin in the 'twenties for us.

Larry Keeley is an innovation strategist who has worked for over four decades to develop more effective innovation methods. Larry is President and co-founder of Doblin Inc, an innovation strategy firm best known for the Ten Types of Innovation framework.  Since 1979 Keeley has worked with many global companies on innovation effectiveness, among them American Express, Apple, Boeing, Coca-Cola, Ford, Gillette, GE, Hallmark, Mars, Mayo Clinic, McDonald's, Novartis, P&G, Pfizer, Rockefeller Foundation, SAS, Shell, Sony, Target, Whirlpool, and Zurich Financial Services.  BusinessWeek named Keeley one of seven Innovation Gurus that are changing the field, and specifically cited Doblin for having many of the most sophisticated tools for delivering innovation effectiveness. They also separately selected Keeley as one of the 27 most influential designers in the world. Keeley teaches graduate innovation strategy classes at the Institute of Design in Chicago, the first design school in the U.S. with a Ph.D. program, where he is also a board member. He lectures in executive education programs at Kellogg Graduate School of Management and is an adjunct faculty member for their core MBA and their Masters of Manufacturing Management programs. He also lectures at University of Chicago, plus business schools worldwide.  I enjoyed tapping into Larry’s incredibly vast reserves of knowledge gained from over four decades in the space of design and innovation. In a corporate innovation landscape that is absolutely awash with charlatans, it’s always refreshing to speak with a critical thinker like Larry who appreciates that ideas are just a tiny part of the battle and that it’s the execution that matters. Expect to take many things away from this conversation, including: 1 - What large companies can do to balance the core business with the exploration of emerging business 2 - Why the focus on building a culture of innovation is misguided and what companies should be doing instead 3 - Three things one must do to become a successful innovator You’ll learn this and more in my thought provoking conversation with the one and only, Larry Keeley.  Topics Discussed: How Larry first got into the space of design and innovation Is today’s fear mongering about tech disruption justified or is this a common pattern that Larry has seen come and go in waves in his four decades in the space? Why the Ten Types of Innovation has stood the test of time Case studies of large organisations successfully balancing the core business with emerging business Why creativity and innovation are two different things Why the pre-occupation of executives in this space with design thinking is short sighted How the human tendency to stick with what’s familiar and do what’s easiest sabotages innovation What slows down large organisations from moving at the pace required to innovate Common misconceptions about innovation How to attract, engage and retain the right talent What more progressive companies in this space are doing differently Why you should build a platform, not a product The importance of empathy in business Show Notes: Doblin Consulting: Doblin.com  Buy the book - Ten Types of Innovation: https://amzn.to/2MpxKYT  I hope you enjoyed this episode. If you’d like to receive a weekly email from me, complete with reflections, books I’ve been reading, words of wisdom and access to blogs, ebooks and more that I’m publishing on a regular basis, just leave your details at www.futuresquared.xyz/subscribe and you’ll receive the very next one. Listen on Apple Podcasts @ goo.gl/sMnEa0 Also available on: Spotify, Google Play, Stitcher and Soundcloud

You may not know it, but the CEO behind America’s favorite all natural soap brand is also a leading figure in the contemporary psychedelic movement. Our guest on the latest Psychedelic Times podcast is David Bronner, Cosmic Engagement Officer of Dr. Bronner’s, MAPS board member, hemp activist, and shining example of how passion-driven business can change the world. David invited our own Joe Mattia to tour the Dr. Bronner’s corporate offices and sit down to discuss his eclectic life story, replete with tales of psychedelic revelations, cannabis churches, suing the DEA and winning, and refocusing the family business to it’s roots with wild success.   Show Notes: David discusses connecting with Rick Doblin and MAPS [2:00] David’s first psilocybin mushroom experience [4:10] Amsterdam adventures: Cannabis Cup and squatting  [5:05] Ego death and revelations on acid and MDMA in a gay trance club [7:00] Integrating his psychedelic experience and becoming a mental health counselor [15:55] The value of resistance and helping humanity to harmonize [17:35] Dolphin overlords, 13th chakra glactivation [19:00] The world needs good men, not spiritual recluses [19:20] Carrying on the Bronner family legacy to unite spaceship earth [23:00] Fighting for hemp seed oil and cannabis  [27:00] Meeting Rick Doblin on the playa and the Zendo Project [31:00] Litigating the DEA and winning [35:00] Coming out of the psychedelic closet [35:30] Board position at MAPS and Burning Man stories [42:10] Psychedelic integration: journaling and meditation [49:50]

Rick Doblin is the founder and executive director of MAPS, the Multidisciplinary Association for Psychedelic Studies. His goal is to help develop contexts, for the legal use of psychedelics and marijuana.

Rick Doblin is the founder and executive director of MAPS, the Multidisciplinary Association for Psychedelic Studies. His goal is to help develop contexts, for the legal use of psychedelics and marijuana.

In this podcast Steve Goldbach & Geoff Tuff from Deloitte sat with Vishal to discuss their recently release book "Detonate". They shared their insights on a cleaner way to create strategies for a future proof and transformation friendly organization. Their tactical suggestions goes a long way in helping install a robust strategy to increase responsiveness. Steve / Geoff's Recommended Read: Geoff's suggestion: Cloud Atlas: A Novel by David Mitchell The Opposable mind https://amzn.to/2rA5BAV The Last Days of Night: A Novel by Graham Moore https://amzn.to/2rAvErB Steve's suggestion: Thinking, Fast and Slow by Daniel Kahneman https://amzn.to/2ryIx5C The Opposable Mind: How Successful Leaders Win Through Integrative Thinking by Roger L. Martin https://amzn.to/2Kds7Y2 The Big Short: Inside the Doomsday Machine by Michael Lewis https://amzn.to/2KaFgRI Podcast Link: iTunes: http://math.im/itunes GooglePlay: http://math.im/gplay Geoff's Bio: GEOFF TUFF is a principal at Deloitte and a senior leader of the firm’s Innovation and Applied Design practices. In the past, he led the design firm Doblin and was a senior partner at Monitor Group, serving as a member of its global Board of Directors before the company was acquired by Deloitte. He has been with some form of Monitor for more than 25 years. He holds degrees from Dartmouth College and Harvard Business School. Steve's Bio: STEVEN GOLDBACH is a principal at Deloitte and serves as the organization’s chief strategy officer. He is also a member of the Deloitte U.S. executive leadership team. Before joining Deloitte, Goldbach was a partner at Monitor Group and head of its New York office. Goldbach helps executives and their teams transform their organizations by making challenging and pragmatic strategy choices in the face of uncertainty. He is an architect, expert practitioner, and teacher of the variety of strategy methodologies developed and used by Monitor Deloitte over the years. Serving clients in many industries, including consumer products, telecommunications, media and health care, Goldbach helps companies combine rigor and creativity to create their own future. He holds degrees from Queen’s University at Kingston and Columbia Business School About #Podcast: #JobsOfFuture is created to spark the conversation around the future of work, worker and workplace. This podcast invite movers and shakers in the industry who are shaping or helping us understand the transformation in work. Want to sponsor? Email us @ info@analyticsweek.com Keywords: #JobsOfFuture #FutureOfWork #FutureOfWorker #FutuerOfWorkplace #Work #Worker #Workplace

In this podcast, Steve Goldbach & Geoff Tuff from Deloitte sat with Vishal to discuss their recently released book "Detonate". They shared their insights on a cleaner way to create strategies for a future proof and transformation friendly organization. Their tactical suggestions go a long way in helping install a robust strategy to increase responsiveness. Timeline: 0:29 The author's journeys. 4:30 Motivation behind writing "Detonate". 8:31 Getting rid of best practices. 12:08 Relevance of "Detonate" for data ops employees. 14:28 Detonate mindset. 22:17 Fixing orthodoxies. 26:19 How can "detonate" serve different kinds of companies? 32:50 Reason behind failing companies. 36:02 Existing company culture vs. detonate mindset. 39:15 "Failure is not ok". 45:10 Aha moments while writing "Detonate". 47:35 The animations in "Detonate". 49:33 Selling the detonate mindset. 52:13 What's next in detonating mindset? 53:54 Steven's and Geoff's favorite reads. 58:15 Key takeaways. Steve / Geoff's Recommended Read: Geoff's suggestion: Cloud Atlas: A Novel by David Mitchell The Opposable mind https://amzn.to/2rA5BAV The Last Days of Night: A Novel by Graham Moore https://amzn.to/2rAvErB Steve's suggestion: Thinking, Fast and Slow by Daniel Kahneman https://amzn.to/2ryIx5C The Opposable Mind: How Successful Leaders Win Through Integrative Thinking by Roger L. Martin https://amzn.to/2Kds7Y2 The Big Short: Inside the Doomsday Machine by Michael Lewis https://amzn.to/2KaFgRI Podcast Link: https://futureofdata.org/solving-futureoforgs-with-detonate-mindset-by-steven_goldbach-geofftuff-futureofdata/ Geoff's Bio: GEOFF TUFF is a principal at Deloitte and a senior leader of the firm's Innovation and Applied Design practices. In the past, he led the design firm Doblin and was a senior partner at Monitor Group, serving as a member of its global Board of Directors before the company was acquired by Deloitte. He has been with some form of Monitor for more than 25 years. He holds degrees from Dartmouth College and Harvard Business School. Steve's Bio: STEVEN GOLDBACH is a principal at Deloitte and serves as the organization's chief strategy officer. He is also a member of the Deloitte U.S. executive leadership team. Before joining Deloitte, Goldbach was a partner at Monitor Group and head of its New York office. Goldbach helps executives and their teams transform their organizations by making challenging and pragmatic strategy choices in the face of uncertainty. He is an architect, expert practitioner, and teacher of the variety of strategy methodologies developed and used by Monitor Deloitte over the years. Serving clients in many industries, including consumer products, telecommunications, media, and health care, Goldbach helps companies combine rigor and creativity to create their own future. He holds degrees from Queen's University at Kingston and Columbia Business School. About #Podcast: #FutureOfData podcast is a conversation starter to bring leaders, influencers, and lead practitioners to discuss their journey to create the data-driven future. Wanna Join? If you or any you know wants to join in, Register your interest @ http://play.analyticsweek.com/guest/ Want to sponsor? Email us @ info@analyticsweek.com Keywords: #FutureOfData #Leadership #Podcast #Future of #Work #Worker & #Workplace

Rick Doblin is the founder of MAPS.org. For over three decades Rick has lead the charge in scientific psychedelic research and education for medical, legal, and cultural contexts of psychedelics and marijuana. Rick came on Delic Radio to talk about the first-ever Phase 3 Trials of MDMA-Assisted Psychotherapy for PTSD, why it's easier to conduct regulatory studies on psychedelics than marijuana, the racist origins of the War on Drugs, and much more. Thanks for listening. Share with a friend!

Will Cook is one of the co-founders of Harvest Box, a rapidly growing snacking company based in Melbourne, Australia. Harvest Box started in 2010 when three mates; Will, George and James, decided to make healthier snacking easy for everyone by creating an unique subscription service of fruit, nut and seed mixes. This innovative format paved the way for national and international distribution of snack packs, health bombs, sultana bubbles and flavours of the world mixes. Now Harvest Box competes in major retailers, cafes, convenience stores, bookstores and wine stores. Find out how they built up this growing business in a crowded marketplace, plus learn about Doblin’s Ten Types of Innovation and how your business could become more competitive long-term.Learn more about Harvest Box snacks and connect with Will:http://www.harvestbox.com.auhttps://www.facebook.com/harvestbox/https://www.instagram.com/harvestbox/Learn more about Doblin’s Ten Types of Innovation:https://www.doblin.com/dist/images/uploads/Doblin_TenTypesBrochure_Web.pdfMany thanks to this episode’s sponsor, the Monash Food Innovation Centre in Melbourne, Australia. Find out how they can help your business become more innovative: https://www.foodinnovationcentre.com.au

Global Product Management Talk is pleased to bring you the next episode of... The Everyday Innovator with host Chad McAllister, PhD. The podcast is all about helping people involved in innovation and managing products become more successful, grow their careers, and STANDOUT from their peers. About the Episode: This episode focuses on platforms — a topic I haven’t discussed yet on this podcast. An effective platform strategy is important for growing organizations as well as those that are starting. There are different perspectives on platforms and this interview primarily explores digital platforms. My guest is Larry Keeley, a strategist who has worked for over three decades to develop effective innovation methods, based in science and analytics. He is President and co-founder of Doblin Inc, an innovation strategy firm known for pioneering comprehensive innovation systems that materially improve innovation success rates and innovation return on investment. Doblin is now a unit of Deloitte Digital. Larry is also the author of the book Ten Types of Innovation, the Discipline of Building Breakthroughs, which you’ll hear us talk about towards the end of the interview.

Lots of new Royale content this week, plus we talk about a few new games including our good friend Smarble's first game: Well Heros! Intro - 0:00 Executioner - 6:00 Balance Update - 17:00 Clan Competition - 50:15 Shields Suck - 55:10 Chest Openings - 58:30 Elders - 1:07:00 Clan Chest Draft - 1:19:30 Well Heros - 1:33:00 Golf Clash - 1:37:31 Force Arena - 1:50:00 War Friends - 2:02:30 Dawn Of Titans - 2:10:20 Royal Revolt II - 2:14:00 Hero Sky - 2:20:30 Mail Bag - 2:25:00

On this episode, we invite on amateur Mycologist Cody Noconi to discuss the history of entheogen use in the human race. Much of the information has been well substantiated by multiple historians and Cody has merely compiled it and brought it to the listening audience. We cover human history from the Fertile Crescent all the way to the enlightenment period, maybe we’ve been stoners for longer than historians think. Once we get into Hermeticism and Alchemy, the connections to entheogen use starts to become very powerful, to the point we can’t ignore its influence. Please take this as a jumping off point to engage in researching this topic for yourself.   Cody’s Sources: Pictures on NMPC website http://nakedmormonismpodcast.com/episodes.html Joseph Smith and Kabbalah: The Occult Connection by Lance S. Owens http://gnosis.org/jskabb1.htm Doblin, Rick. “Dr. Leary’s Concord Prison Experiment: A 34-Year Follow-Up Study.” In Journal of Psychoactive Drugs, p419-426, Vol 30 (4), October – December 1998.  Robert Gordon Wasson, Stella Kramrisch, Jonathan Ott, Carl A. P. Ruck. “Persephone's Quest: Entheogens and the Origins of Religion.” Yale University Press, 1986. 3. Barret, Francis. “The Magus, or Celestial Intelligencer.” London, 1801.    Doblin, Rick. “Pahnke’s ‘Good Friday Experiment’ A Long Term Follow Up and Methodological Critique.” In The Journal of Transpersonal Psychology, Vol. 2. Cambridge, Massachusetts, 1991. 7.    Heinrich, Clark. “Magic Mushrooms in Religion and Alchemy.” Park Street Press, 2002.  Siegel, Ronald K. “Intoxication: The Universal Drive for Mind-Altering Substances.” Park Street Press, 2005. Ott, Johnathon. “Pharmacotheon: Entheogenic drugs, their plant sources and history.” Kennewick, Washington: Natural Products Co, Second Edition Densified, 1996.    Gordon Wasson, Albert Hofmann, Carl A. P. Ruck, Huston Smith. “The Road to Eleusis: Unveiling the Secret of the Mysteries.” North Atlantic Books, 2008.    Scot, Reginald. “The Discoverie of Witchcraft.” England, 1584.    Ruck, Carl. “The Effluents of Deity: Alchemy and Psychoactive Sacraments in Medieval and Renaissance Art.” Carolina Academic Press, 2012    McKenna, Terrance. “Food Of The Gods: The Search for the Original Tree of Knowledge.” Bantam; Reprint edition, January 1, 1993.   Stamets, Paul. “Growing Gourmet and Medicinal Mushrooms.” Ten Speed Press; 3 edition October 25, 2000.    Rush, John. “The Mushroom in Christian Art: The Identity of Jesus in the Development of Christianity.” North Atlantic Books, 2011   Richard Schultes, Christian Ratsch, Albert Hoffman. “Plants of the Gods: Their Sacred, Healing, and Hallucinogenic Powers.” Healing Arts Press; 2nd edition, 2001.    R. Griffiths & W. A. Richards & U. McCann & R. Jesse. “Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.” Springer-Verlag 2006. Received: 20 January 2006 /Accepted: 27 May 2006.    Crowley, Mike. "Oriental Jones and the Medal of Freedom." Invisible College, First Edition, p24-26.    Multidisciplinary Association of Psychedelic Studies - www.maps.org   Information on Psilocybin Therapy for cancer patients - http://www.maps.org/other-psychedelic-research/211-psilocybin-research/psilocybin-studies-in-progress/1268-johns_hopkins_study_of_psilocybin_in_cancer_patients     Show Links:   Scathing Atheist Episode 201 https://audioboom.com/posts/5423399-scathingatheist-201-lump-of-coal-edition Website http://nakedmormonismpodcast.com Twitter @NakedMormonism Facebook https://www.facebook.com/pages/Naked-Mormonism/370003839816311 Patreon http://patreon.com/nakedmormonism Outro music by Jason Comeau http://aloststateofmind.com/ Show Artwork http://weirdmormonshit.com/ Voicemail Line (864)Nake-dMo (625-3366)

Another amazing episode recorded at the 2016 Float Conference in Portland Oregon. Dr. Rick Doblin from MAPS, Multidisciplinary Association for Psychedelic Studies founded in 1986. Dr. Doblin came on the Podcast to discuss all the amazing research MAPS has been doing for the past 20 years. They're projected to have MDMA approved by 2021 to be used as a prescription in treating PTSD. We discuss a variety of topics during this episode and you will no doubt learn something new. Enjoy!   MAPS online- http://www.maps.org/ MAPS on Facebook- https://www.facebook.com/mapsmdma/

Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS).

Crazy is believing in and designing possibilities for the future, whilst everyone tells you you’re just damn nuts Chris Forrest is Innovation Project Manager in Doblin’s Toronto, Canada office. Doblin is the innovation arm of Deloitte which believes that change is inevitable and increasing at an exponential rate so works with you to move beyond this seemingly chaotic landscape and seize the opportunities available. Chris specializes in leading large scale innovation transformation programs, working with clients to define their innovation strategy, build capabilities and conceive their breakthrough innovation concepts. As a member of Deloitte Canada’s Innovation Program, Chris worked on establishing an innovation ecosystem and foresight function for the firm, developing thought leadership on disruptive forces impacting professional services, building design thinking capabilities and inspiring the development of new innovation systems and services.

Raghu is joined by Rick Doblin, head of (take a deep breath for this one) Multidisciplinary Association for Psychedelic Studies, otherwise known as MAPS! Rick describes some of the things that helped him to see into a new reality, including his faith-puncturing Bar Mitzvah, which forced him out of what would have been a “manufactured” mystical connection. Rick then goes on to describe his introduction to LSD in college, and how he discovered a new way of processing information and consciousness from those experiences; it opened him up to the emotional world. Other topics discussed include: - The emotional stability of our culture -  Using psychedelics for healing and therapy - Using psychedelics to rail against the “us” and “them” rhetoric present between countries, religions, races and creeds. -  Doblin’s discovery of the underground psychedelic community - How LSD opened the “Westerners” up to to a visceral understanding of their time with Neem Karoli Baba (Maharaji) when they traveled to India - How do the subjects of the “Good Friday” experiment look back on their psychedelic experiences today? - How does MDMA work? - What is The Theory of Causal Indifference? - How can psychedelics help with PTSD and other trauma?  

Joe Mattia, founder of psychedelic resource and news site PsychedelicTimes.com, interviews M.A.P.S. (Multidisciplinary Association for Psychedelic Studies) founder Rick Doblin, on his experiences and his insights regarding the future of MDMA assisted psychotherapy. Rick shares some personal history, and references his own "coming out of the psychedelic closet." There's a mention of the Zendo, the harm reduction program set up by MAPS at festivals, a story about MAPS' beginnings at Esalen, and the use of Cannabis in the clinical trials.   Show Notes The history of psychedelics in the US: From William James’ experimentation with nitrous oxide in 1890 to the Controlled Substance Act in 1970 [3:58] The 1970s: Rick’s introduction to LSD, attendance of Stan Groff’s workshop at Esalen, and dropping out of school [8:00] The 1980s: Rick’s studies at Esalen, personal discovery of MDMA, and the start of MAPS as a psychedelic and medical marijuana pharmaceutical non-profit company [9:45] Why it’s important to work within the system [19:00] A possible alliance with the police, who experience high rates of PTSD and could benefit from this type of therapy [25:32] Current status of MDMA studies in Switzerland, Israel, Canada, and the US [29:16] Psilocybin research as end-of-life therapy [44:28] Phase 2 of MDMA research [46:46] Pros, cons, protocol, and challenges of using marijuana for PTSD [52:52] Phase 3 of MDMA research: How MAPS retains its nonprofit status by creating a Public Benefit Corp. [1:16:47] Phase 3 of MDMA research (cont): Therapist training program through MAPS and CIIS certification for psychedelic therapy [1:19:00] Zendo Project at Burning Man [1:30:43]  

Tom Shroder is a journalist, Pulitzer prize winning editor, and the author of Acid Test: LSD, Ecstacy, and the Power to Heal. Tom explains the process of MDMA assisted psychotherapy along with the history of MDMA's rise from party drug to a harbinger of hope.

Doblin on LSD: Addiction, Clinical Results & Spirituality by Dr. Richard L. Miller

Doblin on LSD & Psilocybin: End of Life & Anxiety by Dr. Richard L. Miller

Doblin on Peyote: Legality, Safety & Clinical Results by Dr. Richard L. Miller

Doblin on Peyote: Legality, Safety & Clinical Results by Dr. Richard L. Miller

Doblin on MDMA: Clinical Results & Risks by Dr. Richard L. Miller

Doblin on MDMA: User Experience, Suppression of Information & Legal History by Dr. Richard L. Miller

Doblin on MDMA & LSD: Spirituality & Interconnectedness by Dr. Richard L. Miller

Doblin on Prescription Drugs: Safety by Dr. Richard L. Miller

Doblin on Ayahuasca: Spirituality, Safety, Efficacy & Legality by Dr. Richard L. Miller

Doblin on Ibogaine: User Experience, Addiction, Clinical Results & Safety by Dr. Richard L. Miller

Doblin on MDMA: Pharmacology & Safety by Dr. Richard L. Miller

Doblin on MDMA: Safety, Clinical Results & User Experience by Dr. Richard L. Miller

Doblin on Ayahuasca, LSD, Mescaline & Ketamine: Addiction and Depression by Dr. Richard L. Miller

Doblin on LSD: Clinical Studies, History & Anxiety by Dr. Richard L. Miller

Doblin on MDMA: Pharmacology & Ecstasy vs. MDMA by Dr. Richard L. Miller

In our first episode of the HighExistence podcast we talk with Rick Doblin who is the founder of the non-profit organization MAPS, a true pioneering group of people researching the healing effects of Psilocybin, MDMA and LSD. We discuss the new wave of research about the healing power of psychedelics, spiritual experiences and what he thinks of the famous quote by Alan Watts, "If you got the message, hang up the phone." [EXCLUSIVE OFFER FOR PODCAST SUBSCRIBERS] Take the ultimate life experiment, our 30 Challenges to Enlightenment Course, a complete spiritual path to help you overcome the limitations of your mind and to embody the highest philosophical realizations. Use the code ‘WISDOM’ at checkout to get a huge 25% off the course, available only to podcast subscribers at store.highexistence.com.

Larry Keeley is a strategist who has worked for over three decades to develop more effective innovation methods. Larry is President and co-founder of Doblin Inc, an innovation strategy firm known for pioneering comprehensive innovation systems that materially improve innovation success rates. Doblin is now a unit of Deloitte Consulting, where Keeley serves as a Director. He is also co-author of Ten Types of Innovation: The Discipline of Building Breakthroughs. In this interview we talk about what innovation looks like and how to get it to happen more in your organizations.

Listen NowOf the two and a half million Americans that die annually, less than half, or 45%, die under hospice care. About one-third of these deaths are cancer related the remainder are moreover from heart and lung disease and dementia.  Of the over 5,000 hospice providers nearly two-thirds are for profit.  Over 80% of all hospice care is paid for by Medicare.  While hospice care is ever-increasingly becoming accepted by the public, the program's benefits are compromised largely due to the fact that over one-third of hospice enrolled decedents were enrolled in the program for too short a period of time, or less than seven days.  During this 21 minute podcast, Dr. Doblin discusses why he became a hospice physician, what makes for good hospice care, why the benefit remains under-utilized, what constitutes a "good death," how might hospice and palliative care be improved and how these services might better fit  in ever-evolving changes in the health care industry.     Dr. Bruce H. Doblin is currently a Physician in the Department of Internal Medicine at Northwestern Memorial Hospital.  He also serves as an Instructor of Clinical Medicine-Internal Medicine at the Northwestern University Feinberg School of Medicine.  Previously, Dr. Doblin served for over ten years as the Medical Director for Seasons Hospice and Palliative Care in Chicago.  Dr. Doblin earned his BA in Economics at Williams College and his MD and Masters in Public Health from Northwestern University.  He completed fellowship training at UCLA in health services research and at the University of Chicago in Clinical Medical Ethics. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.thehealthcarepolicypodcast.com

Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS).

At the MAPS Psychedelic Science Conference 2010 with experiential journalist Rak Razam: * Rick Doblin talks about the almost 25-year history of MAPS, the Multi-Disciplinary Association of Psychedelic Studies, the "end of the beginning of the Psychedelic Renaissance" and why Western culture is now ready for the psychedelic experience and a global spirituality. Rick discusses the return of the 60s elders and the new psychedelic generation, the spiritual approach to entheogens paralleling the medical psy-resurgence, the need to turn on, tune in and stay in the culture as we integrate the numinous, and much more... * Charles Grob outlines some of his landmark studies with entheogenic medicine, including the ayahuasca research of the early 1990s on serotonin-platelet rejuvenation after regular ayahuasca usage and the current cultural uptake; MDMA tests on volunteers and the difference between man-made and indigenous medicines; and psilocybin with late-stage cancer patients treating anxiety. Sacred medicines allow exploration of the great mysteries, Grob says, and induce mystical experiences that are at the root of all true healing... * Ralph Metzner discusses the PTSD-MDMA tests MAPS is sponsoring and the possibility of psychedelics as a soma for the masses; his history with Tim Leary and the Harvard years and the need to move drugs out of law enforcement and back into public health system. background image courtesy of Tim Parish and the Journeybook This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported License.